{"parse":{"title":"HIV and pregnancy","pageid":43456997,"revid":858584416,"text":{"*":"<div class=\"mw-parser-output\"><p><b>HIV in pregnancy</b> is the presence of <a href=\"/wiki/HIV\" title=\"HIV\">HIV</a> in a woman while she is <a href=\"/wiki/Pregnancy\" title=\"Pregnancy\">pregnant</a>. HIV in pregnancy is of concern because women with <a href=\"/wiki/HIV/AIDS\" title=\"HIV/AIDS\">HIV/AIDS</a> may transmit the infection to their child during pregnancy, <a href=\"/wiki/Childbirth\" title=\"Childbirth\">childbirth</a> and while <a href=\"/wiki/Breastfeeding\" title=\"Breastfeeding\">breastfeeding</a>. However, the risk of <a href=\"/wiki/Vertically_transmitted_infection\" title=\"Vertically transmitted infection\">mother-to-child transmission</a> of HIV may be reduced by treatment of the HIV infection with <a href=\"/wiki/Management_of_HIV/AIDS\" title=\"Management of HIV/AIDS\">antiretroviral therapy</a> (ART). This lifelong therapy may be initiated in women before, during, and after pregnancy. After delivery, children are also given the medication temporarily as a <a href=\"/wiki/Post-exposure_prophylaxis\" title=\"Post-exposure prophylaxis\">prophylactic</a> measure to reduce the risk of infection. Because HIV may also be spread through <a href=\"/wiki/Breast_milk\" title=\"Breast milk\">breast milk</a>, mothers in the United States who are infected are encouraged to avoid <a href=\"/wiki/Breastfeed\" class=\"mw-redirect\" title=\"Breastfeed\">breastfeeding</a>.<sup id=\"cite_ref-aidsinfo2012_1-0\" class=\"reference\"><a href=\"#cite_note-aidsinfo2012-1\">&#91;1&#93;</a></sup> However, in <a href=\"/wiki/Developing_countries\" class=\"mw-redirect\" title=\"Developing countries\">developing countries</a> such as South Africa, where the risk of death of the infant associated with avoiding <a href=\"/w/index.php?title=Exclusive_breastfeeding&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Exclusive breastfeeding (page does not exist)\">exclusive breastfeeding</a> is higher than the risk of contracting HIV, exclusive breastfeeding in a mother who is virally suppressed is encouraged.<sup id=\"cite_ref-:9_2-0\" class=\"reference\"><a href=\"#cite_note-:9-2\">&#91;2&#93;</a></sup>\n</p><p>Infection with HIV/AIDS is not a <a href=\"/wiki/Contraindication\" title=\"Contraindication\">contraindication</a> to pregnancy. Women with the disease may choose to become pregnant if they desire, however, they are encouraged to talk with their doctors beforehand. Some women are unaware they have the disease until they become pregnant. In this case, they should begin antiretroviral therapy as soon as possible.<sup id=\"cite_ref-aidsinfo2012_1-1\" class=\"reference\"><a href=\"#cite_note-aidsinfo2012-1\">&#91;1&#93;</a></sup> With the appropriate treatment, the risk of <a href=\"/wiki/HIV/AIDS#Mother-to-child\" title=\"HIV/AIDS\">mother-to-child infection</a> can be reduced to below 1%.<sup id=\"cite_ref-Mother2010_3-0\" class=\"reference\"><a href=\"#cite_note-Mother2010-3\">&#91;3&#93;</a></sup> Without treatment, the risk of transmission is 15\u201345%.<sup id=\"cite_ref-4\" class=\"reference\"><a href=\"#cite_note-4\">&#91;4&#93;</a></sup>\n</p><p>There are approximately 1.4 million HIV positive women who become pregnant and contribute to more than 300,000 neonatal and fetal deaths each year.<sup id=\"cite_ref-5\" class=\"reference\"><a href=\"#cite_note-5\">&#91;5&#93;</a></sup> With the use of ART, transmission of HIV from the mother to child has decreased according to reports by the <a href=\"/wiki/World_Health_Organization\" title=\"World Health Organization\">World Health Organization</a> (WHO). In 2009, there were an estimated 400,000 children born with HIV and by 2013, there were 240,000.<sup id=\"cite_ref-6\" class=\"reference\"><a href=\"#cite_note-6\">&#91;6&#93;</a></sup> Countries in <a href=\"/wiki/Sub-Saharan_Africa\" title=\"Sub-Saharan Africa\">Sub-Saharan Africa</a> are worst affected by the HIV/AIDS pandemic. In 2010, 30% of all pregnancies in the region were affected by HIV. In 2011, HIV was responsible for 50% of the deaths of children below the age of five.<sup id=\"cite_ref-7\" class=\"reference\"><a href=\"#cite_note-7\">&#91;7&#93;</a></sup> In the <a href=\"/wiki/United_States\" title=\"United States\">United States</a>, fewer than 200 babies are born with HIV every year.<sup id=\"cite_ref-aidsinfo2012_1-2\" class=\"reference\"><a href=\"#cite_note-aidsinfo2012-1\">&#91;1&#93;</a></sup>\n</p><p>As of 2015, <a href=\"/wiki/Cuba\" title=\"Cuba\">Cuba</a> has become the first country in the world to eradicate mother-to-child transmission of HIV. In 2010, the WHO partnered with the <a href=\"/wiki/Pan_American_Health_Organization\" title=\"Pan American Health Organization\">Pan American Health Organization</a> (PAHO) to implement an initiative that would provide early <a href=\"/wiki/Prenatal_care\" title=\"Prenatal care\">prenatal care</a> and <a href=\"/wiki/HIV_Testing\" class=\"mw-redirect\" title=\"HIV Testing\">HIV testing</a> for all pregnant women in Cuba. For women who tested positive, ART was provided for both the mother and child, <a href=\"/wiki/Cesarean_sections\" class=\"mw-redirect\" title=\"Cesarean sections\">cesarean sections</a> were performed, and alternatives to breastfeeding were provided. In implementing these measures, the country was successfully able to eradicate HIV transmission during pregnancy.<sup id=\"cite_ref-:3_8-0\" class=\"reference\"><a href=\"#cite_note-:3-8\">&#91;8&#93;</a></sup>\n</p>\n<div id=\"toc\" class=\"toc\"><input type=\"checkbox\" role=\"button\" id=\"toctogglecheckbox\" class=\"toctogglecheckbox\" style=\"display:none\" /><div class=\"toctitle\" lang=\"en\" dir=\"ltr\"><h2>Contents</h2><span class=\"toctogglespan\"><label class=\"toctogglelabel\" for=\"toctogglecheckbox\"></label></span></div>\n<ul>\n<li class=\"toclevel-1 tocsection-1\"><a href=\"#Pregnancy_planning\"><span class=\"tocnumber\">1</span> <span class=\"toctext\">Pregnancy planning</span></a></li>\n<li class=\"toclevel-1 tocsection-2\"><a href=\"#HIV_testing_in_pregnancy\"><span class=\"tocnumber\">2</span> <span class=\"toctext\">HIV testing in pregnancy</span></a></li>\n<li class=\"toclevel-1 tocsection-3\"><a href=\"#Prevention_of_mother-to-child_transmission\"><span class=\"tocnumber\">3</span> <span class=\"toctext\">Prevention of mother-to-child transmission</span></a>\n<ul>\n<li class=\"toclevel-2 tocsection-4\"><a href=\"#Indications_to_start_medications\"><span class=\"tocnumber\">3.1</span> <span class=\"toctext\">Indications to start medications</span></a></li>\n<li class=\"toclevel-2 tocsection-5\"><a href=\"#Medications_during_pregnancy\"><span class=\"tocnumber\">3.2</span> <span class=\"toctext\">Medications during pregnancy</span></a></li>\n<li class=\"toclevel-2 tocsection-6\"><a href=\"#Nutritional_supplements\"><span class=\"tocnumber\">3.3</span> <span class=\"toctext\">Nutritional supplements</span></a></li>\n<li class=\"toclevel-2 tocsection-7\"><a href=\"#Labor_and_delivery\"><span class=\"tocnumber\">3.4</span> <span class=\"toctext\">Labor and delivery</span></a></li>\n<li class=\"toclevel-2 tocsection-8\"><a href=\"#Breastfeeding\"><span class=\"tocnumber\">3.5</span> <span class=\"toctext\">Breastfeeding</span></a></li>\n</ul>\n</li>\n<li class=\"toclevel-1 tocsection-9\"><a href=\"#Other_considerations_during_pregnancy\"><span class=\"tocnumber\">4</span> <span class=\"toctext\">Other considerations during pregnancy</span></a></li>\n<li class=\"toclevel-1 tocsection-10\"><a href=\"#Postnatal_care\"><span class=\"tocnumber\">5</span> <span class=\"toctext\">Postnatal care</span></a></li>\n<li class=\"toclevel-1 tocsection-11\"><a href=\"#References\"><span class=\"tocnumber\">6</span> <span class=\"toctext\">References</span></a></li>\n<li class=\"toclevel-1 tocsection-12\"><a href=\"#External_links\"><span class=\"tocnumber\">7</span> <span class=\"toctext\">External links</span></a></li>\n</ul>\n</div>\n\n<h2><span class=\"mw-headline\" id=\"Pregnancy_planning\">Pregnancy planning</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=HIV_and_pregnancy&amp;action=edit&amp;section=1\" title=\"Edit section: Pregnancy planning\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>In couples where the male and female are both HIV positive, conception may occur normally without concern for disease transmission. However, in couples where only one partner is HIV positive there is risk of transmitting the infection to the uninfected partner. These couples, known as <a href=\"/wiki/Serodiscordant\" title=\"Serodiscordant\">serodiscordant</a> couples, are advised not to engage in unprotected intercourse. Instead, <a href=\"/wiki/Assisted_reproductive_technology\" title=\"Assisted reproductive technology\">assistive reproductive methods</a> are recommended.<sup id=\"cite_ref-:0_9-0\" class=\"reference\"><a href=\"#cite_note-:0-9\">&#91;9&#93;</a></sup> In all serodiscordant couples, the infected partner is advised to begin ART so that their <a href=\"/wiki/Viral_load_monitoring_for_HIV\" title=\"Viral load monitoring for HIV\">viral load</a> is undetectable prior to attempting conception.<sup id=\"cite_ref-10\" class=\"reference\"><a href=\"#cite_note-10\">&#91;10&#93;</a></sup>\n</p><p>In couples where the woman is HIV negative and the man is HIV positive, sperm is collected from the male partner and HIV is removed from the specimen using a technique called <a href=\"/wiki/Sperm_washing\" title=\"Sperm washing\">sperm washing</a>. This process is then followed by <a href=\"/wiki/Intrauterine_insemination\" class=\"mw-redirect\" title=\"Intrauterine insemination\">intrauterine insemination</a> (IUI) or <a href=\"/wiki/In_vitro_fertilization\" class=\"mw-redirect\" title=\"In vitro fertilization\">in vitro fertilization</a> (IVF). Couples may also use donor sperm from a non-infected male if desired.<sup id=\"cite_ref-Savasi2013_11-0\" class=\"reference\"><a href=\"#cite_note-Savasi2013-11\">&#91;11&#93;</a></sup>\n</p><p>In couples where the woman is HIV positive and the man is HIV negative, <a href=\"/wiki/Artificial_insemination\" title=\"Artificial insemination\">artificial insemination</a> is recommended.<sup id=\"cite_ref-Savasi2013_11-1\" class=\"reference\"><a href=\"#cite_note-Savasi2013-11\">&#91;11&#93;</a></sup>\n</p><p>In areas where assistive reproductive techniques, such as IUI or IVF, are not available, techniques used during intercourse can be attempted to reduce, but not eliminate, the risk of HIV transmission.<sup id=\"cite_ref-lvguidelines_12-0\" class=\"reference\"><a href=\"#cite_note-lvguidelines-12\">&#91;12&#93;</a></sup> Most importantly, the <a href=\"/wiki/HPTN_052\" title=\"HPTN 052\">HPTN 052</a> trial showed that when HIV infected partners were on ART and their viral load was undetectable no transmission occurred; in partners with a detectable viral load on ART there was 96% less transmission.<sup id=\"cite_ref-13\" class=\"reference\"><a href=\"#cite_note-13\">&#91;13&#93;</a></sup>\n</p><p>Many serodiscordant couples use <a href=\"/wiki/Pre-exposure_prophylaxis\" title=\"Pre-exposure prophylaxis\">pre-exposure prophylaxis</a> (PrEP) to limit transmission of the infection to the uninfected partner. Daily use of PrEP has been shown to decrease transmission of the infection by an average of 63\u201375%. However, use of PrEP during pregnancy has not yet been studied and its long-term effects on the foetus are unknown.<sup id=\"cite_ref-14\" class=\"reference\"><a href=\"#cite_note-14\">&#91;14&#93;</a></sup>\n</p><p>Although assisted reproductive techniques are available for serodiscordant couples, there are still limitations to achieving a successful pregnancy. Women with HIV have been shown to have decreased fertility, which can affect the available reproductive options.<sup id=\"cite_ref-15\" class=\"reference\"><a href=\"#cite_note-15\">&#91;15&#93;</a></sup> Women with HIV are also more likely to be infected with other sexually transmitted diseases, placing them at higher risk for infertility. Males with HIV appear to have decreased semen volume and sperm motility, which decreases their fertility.<sup id=\"cite_ref-:0_9-1\" class=\"reference\"><a href=\"#cite_note-:0-9\">&#91;9&#93;</a></sup> ART may also affect both male and female fertility and some drugs can be <a href=\"/wiki/Teratogen\" class=\"mw-redirect\" title=\"Teratogen\">toxic</a> to embryos.<sup id=\"cite_ref-16\" class=\"reference\"><a href=\"#cite_note-16\">&#91;16&#93;</a></sup> Additionally, there have been cases where an HIV-negative partner was infected with the disease despite artificial insemination with washed sperm.<sup id=\"cite_ref-17\" class=\"reference\"><a href=\"#cite_note-17\">&#91;17&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"HIV_testing_in_pregnancy\">HIV testing in pregnancy</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=HIV_and_pregnancy&amp;action=edit&amp;section=2\" title=\"Edit section: HIV testing in pregnancy\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<div role=\"note\" class=\"hatnote navigation-not-searchable\">Further information: <a href=\"/wiki/Diagnosis_of_HIV/AIDS\" title=\"Diagnosis of HIV/AIDS\">Diagnosis of HIV/AIDS</a></div>\n<p>The <a href=\"/wiki/Centers_for_Disease_Control_and_Prevention\" title=\"Centers for Disease Control and Prevention\">Centers for Disease Control and Prevention</a> (CDC) recommends <a href=\"/wiki/Diagnosis_of_HIV/AIDS\" title=\"Diagnosis of HIV/AIDS\">HIV testing</a> for all pregnant women as a part of routine prenatal care. The test is usually performed in the first trimester of pregnancy with other routine laboratory tests. HIV testing is recommended because HIV-infected women who do not receive testing are more likely to transmit the infection to their children.<sup id=\"cite_ref-:1_18-0\" class=\"reference\"><a href=\"#cite_note-:1-18\">&#91;18&#93;</a></sup>\n</p><p>HIV testing may be offered to pregnant women on an <i>opt-in</i> or an <i>opt-out</i> basis. In the <i>opt-in</i> model, women are counseled on HIV testing and elect to receive the test by signing a consent form. In the <i>opt-out</i> model, the HIV test is automatically performed with other routine prenatal tests. If a woman does not want to be tested for HIV, she must specifically refuse the test and sign a form declining testing. The CDC recommends <i>opt-out</i> testing for all pregnant women because it improves disease detection and treatment and helps reduce transmission to children.<sup id=\"cite_ref-:1_18-1\" class=\"reference\"><a href=\"#cite_note-:1-18\">&#91;18&#93;</a></sup>\n</p><p>If a woman chooses to decline testing, she will not receive the test. However, she will continue to receive HIV counseling throughout the pregnancy so that she may be as informed as possible about the disease and its impact. She will be offered HIV testing at all stages of her pregnancy in case she changes her mind.<sup id=\"cite_ref-19\" class=\"reference\"><a href=\"#cite_note-19\">&#91;19&#93;</a></sup>\n</p><p>HIV testing begins with a <a href=\"/wiki/Screening_(medicine)\" title=\"Screening (medicine)\">screening test</a>. The most common screening test is the <a href=\"/wiki/Diagnosis_of_HIV/AIDS\" title=\"Diagnosis of HIV/AIDS\">rapid HIV antibody test</a> which tests for HIV <a href=\"/wiki/Antibody\" title=\"Antibody\">antibodies</a> in blood, urine, or oral fluid. HIV antibodies are only produced if an individual is infected with the disease. Therefore, presence of the antibodies is indicative of an HIV infection. Sometimes, however, a person may be infected with HIV but the body has not produced enough antibodies to be detected by the test. If a woman has risk factors for HIV infection but tests negative on the initial screening test, she should be retested in 3 months to confirm that she does not have HIV.<sup id=\"cite_ref-:2_20-0\" class=\"reference\"><a href=\"#cite_note-:2-20\">&#91;20&#93;</a></sup> Another screening test that is more specific is the <a href=\"/wiki/Diagnosis_of_HIV/AIDS\" title=\"Diagnosis of HIV/AIDS\">HIV antigen/antibody test</a>. This is a newer blood test that can detect HIV infection quicker than the antibody test because it detects both virus particles and antibodies in the blood.<sup id=\"cite_ref-pmid23911678_21-0\" class=\"reference\"><a href=\"#cite_note-pmid23911678-21\">&#91;21&#93;</a></sup>\n</p><p>Any woman who has a positive HIV screening test must receive follow-up testing to confirm the diagnosis. The follow-up test can differentiate HIV-1 from HIV-2 and is a more specific antibody test. It may also detect the virus directly in the bloodstream.<sup id=\"cite_ref-:2_20-1\" class=\"reference\"><a href=\"#cite_note-:2-20\">&#91;20&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Prevention_of_mother-to-child_transmission\">Prevention of mother-to-child transmission</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=HIV_and_pregnancy&amp;action=edit&amp;section=3\" title=\"Edit section: Prevention of mother-to-child transmission\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>HIV/AIDS may be <a href=\"/wiki/Vertically_transmitted_infection\" title=\"Vertically transmitted infection\">vertically transmitted</a> from a mother to her child. This means the infection may be spread during pregnancy, <a href=\"/wiki/Childbirth\" title=\"Childbirth\">labor</a>, delivery, or breastfeeding. 70% of transmissions are believed to occur during delivery when the baby comes into direct contact with the mother's infected blood or genital secretions/fluid in the birth canal. 30% of infections occur <a href=\"/wiki/In_utero\" title=\"In utero\">in utero</a> during the pregnancy with 66% occurring within the last 14 days of a pregnancy.<sup id=\"cite_ref-22\" class=\"reference\"><a href=\"#cite_note-22\">&#91;22&#93;</a></sup> The mechanism for in utero infection is not well understood, but the current belief is that infected maternal secretions may cross the placenta during the pregnancy.<sup id=\"cite_ref-23\" class=\"reference\"><a href=\"#cite_note-23\">&#91;23&#93;</a></sup>\n</p><p>The risk of HIV transmission from a mother to child is most directly related to the plasma <a href=\"/wiki/Viral_load\" title=\"Viral load\">viral load</a> of the mother. Untreated mothers with a viral load &gt;100,000 copies/ml have a transmission risk of over 50%.<sup id=\"cite_ref-24\" class=\"reference\"><a href=\"#cite_note-24\">&#91;24&#93;</a></sup> For women with a viral load &lt;1000 copies/ml, the risk of transmission is less than 1%.<sup id=\"cite_ref-25\" class=\"reference\"><a href=\"#cite_note-25\">&#91;25&#93;</a></sup> In general, the lower the viral load the lower the risk of transmission. For this reason, ART is recommended throughout the pregnancy so that viral load levels remain as low as possible and the risk of transmission is reduced.\n</p><p>Women with an established diagnosis of HIV often begin ART before becoming pregnant to treat the infection. It is recommended that all pregnant women begin ART regardless of CD4 counts or viral load to reduce the risk of transmission. The earlier ART is initiated, the more likely the viral load will be suppressed by the time of delivery.<sup id=\"cite_ref-26\" class=\"reference\"><a href=\"#cite_note-26\">&#91;26&#93;</a></sup> Some women are concerned about using ART early in the pregnancy, as babies are most susceptible to drug toxicities during the first trimester.  However, delay in ART initiation may prove less effective in reducing infection transmission.<sup id=\"cite_ref-27\" class=\"reference\"><a href=\"#cite_note-27\">&#91;27&#93;</a></sup>\n</p><p>Antiretroviral therapy is used at the following times in pregnancy to reduce the risk of mother-to-child transmission of HIV:<sup id=\"cite_ref-aidsinfo2012_1-3\" class=\"reference\"><a href=\"#cite_note-aidsinfo2012-1\">&#91;1&#93;</a></sup> \n</p>\n<ul><li>During pregnancy: pregnant women infected with HIV receive an oral regimen of at least three different anti-HIV medications (such as <a href=\"/wiki/Tenofovir_disoproxil\" title=\"Tenofovir disoproxil\">tenofovir</a>, <a href=\"/wiki/Emtricitabine\" title=\"Emtricitabine\">emtricitabine</a> and <a href=\"/wiki/Efavirenz\" title=\"Efavirenz\">efavirenz</a>).</li>\n<li>During labor and delivery: pregnant women infected with HIV and already on triple ART are recommended to continue with their oral regimen. If their viral load is &gt;1,000 copies/ml or there is question about whether medications have been taken consistently, then <a href=\"/wiki/Intravenous_therapy\" title=\"Intravenous therapy\">intravenous</a> <a href=\"/wiki/Zidovudine\" title=\"Zidovudine\">zidovudine</a> (AZT) is added at the time of delivery.<sup id=\"cite_ref-lvguidelines_12-1\" class=\"reference\"><a href=\"#cite_note-lvguidelines-12\">&#91;12&#93;</a></sup> Pregnant women who have not been on ART prior to delivery or who have been on ART for less than four weeks should also be given intravenous AZT or a single dose of <a href=\"/wiki/Nifedipine\" title=\"Nifedipine\">nifedipine</a> (NVD), tenofovir (TDF) and emtricitabine (FTC) and a three-hourly dose of AZT.<sup id=\"cite_ref-:10_28-0\" class=\"reference\"><a href=\"#cite_note-:10-28\">&#91;28&#93;</a></sup></li></ul>\n<h3><span class=\"mw-headline\" id=\"Indications_to_start_medications\">Indications to start medications</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=HIV_and_pregnancy&amp;action=edit&amp;section=4\" title=\"Edit section: Indications to start medications\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>According to current recommendations by the WHO, US CDC and U.S. Department of Health and Human Services (DHHS), all individuals with HIV should begin ART. The recommendation is stronger under the following conditions:<sup id=\"cite_ref-:4_29-0\" class=\"reference\"><a href=\"#cite_note-:4-29\">&#91;29&#93;</a></sup>\n</p>\n<ul><li><a href=\"/wiki/CD4_count\" class=\"mw-redirect\" title=\"CD4 count\">CD4 count</a> below 350 cells/mm<sup>3</sup></li>\n<li>High viral load (&gt;100,000 copies/ml)</li>\n<li>Progression of HIV to AIDS</li>\n<li>Development of HIV-related infections and illnesses</li>\n<li>Pregnancy</li></ul>\n<p>Women are encouraged to begin treatment as soon as they are diagnosed with HIV. If they are diagnosed prior to pregnancy, they should continue with ART during the pregnancy. If the diagnosis of HIV is made during the pregnancy, ART should be initiated immediately.<sup id=\"cite_ref-:4_29-1\" class=\"reference\"><a href=\"#cite_note-:4-29\">&#91;29&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Medications_during_pregnancy\">Medications during pregnancy</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=HIV_and_pregnancy&amp;action=edit&amp;section=5\" title=\"Edit section: Medications during pregnancy\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>The goal of antiretroviral use during pregnancy is to reduce the risk of transmission of HIV from mother to child. It is important to choose medications that are safe for the mother and the fetus and which are effective at decreasing the total viral load. Some studies have shown an increase in stillbirths, preterm delivery, and delayed fetal growth in women using high doses of antiretroviral drugs during pregnancy. However, the overall benefits of ART are believed to outweigh the risks and all women are encouraged to use ART for the duration of their pregnancy.<sup id=\"cite_ref-30\" class=\"reference\"><a href=\"#cite_note-30\">&#91;30&#93;</a></sup>\n</p><p>Due to physiological changes in the body during pregnancy, it may be necessary to alter the dosing of medications so that they remain effective. Generally, the dose or the frequency of dosing are increased to account for these changes.\n</p><p>The recommended ART regimen for HIV-positive pregnant women consists of drugs from 4 different classes of medications listed below. In the United States, the favored regimen is a three-drug regimen where the first two drugs are NRTIs and the third is either a protease inhibitor, an integrase inhibitor, or an NNRTI.<sup id=\"cite_ref-lvguidelines_12-2\" class=\"reference\"><a href=\"#cite_note-lvguidelines-12\">&#91;12&#93;</a></sup>\n</p>\n<ul><li><a href=\"/wiki/Nucleoside_reverse_transcriptase_inhibitor\" class=\"mw-redirect\" title=\"Nucleoside reverse transcriptase inhibitor\">Nucleoside reverse transcriptase inhibitors</a> (NRTIs) are considered the \"backbone\" of ART and 2 medications are generally used in combination. Due to its known safety profile and extensive use in pregnant patients, <a href=\"/wiki/Zidovudine\" title=\"Zidovudine\">zidovudine</a>-<a href=\"/wiki/Lamivudine\" title=\"Lamivudine\">lamivudine</a> (ZDV/3TC) is the preferred choice as the NRTI backbone. Zidovudine may worsen anemia, so patients with anemia are advised to use an alternative agent. For women who are coinfected with <a href=\"/wiki/Hepatitis_B\" title=\"Hepatitis B\">hepatitis B</a>, <a href=\"/wiki/Tenofovir\" class=\"mw-redirect\" title=\"Tenofovir\">tenofovir</a> (TDF) with either <a href=\"/wiki/Emtricitabine\" title=\"Emtricitabine\">emtricitabine</a> (FTC) or lamivudine is the preferred NRTI backbone.<sup id=\"cite_ref-lvguidelines_12-3\" class=\"reference\"><a href=\"#cite_note-lvguidelines-12\">&#91;12&#93;</a></sup> NRTI use may cause <a href=\"/wiki/Lactic_acidosis\" title=\"Lactic acidosis\">lactic acidosis</a> in some women, so it is important to monitor patients for this complication. Deaths from lactic acidosis and liver failure have been associated with the use of two NRTIs, <a href=\"/wiki/Stavudine\" title=\"Stavudine\">stavudine</a> and <a href=\"/wiki/Didanosine\" title=\"Didanosine\">didanosine</a> (d4t and ddl, respectively); therefore, combinations involving these drugs should be avoided in pregnancy.<sup id=\"cite_ref-aidsinfo2012_1-4\" class=\"reference\"><a href=\"#cite_note-aidsinfo2012-1\">&#91;1&#93;</a></sup></li>\n<li><a href=\"/wiki/Protease_inhibitor_(pharmacology)\" title=\"Protease inhibitor (pharmacology)\">Protease inhibitors</a> (PIs) have been studied extensively in pregnancy and are therefore the preferred third drug in the regimen. <a href=\"/wiki/Atazanavir\" title=\"Atazanavir\">Atazanavir</a>-<a href=\"/wiki/Ritonavir\" title=\"Ritonavir\">ritonavir</a> (ATV/r) and <a href=\"/wiki/Darunavir\" title=\"Darunavir\">darunavir</a>-ritonavir (DRV/r) are two of the most common PIs used during pregnancy. There is conflicting data regarding their association with preterm births, so women who are at a high risk for premature delivery are advised not to use PIs.<sup id=\"cite_ref-lvguidelines_12-4\" class=\"reference\"><a href=\"#cite_note-lvguidelines-12\">&#91;12&#93;</a></sup> Some PIs have been associated with <a href=\"/wiki/Hyperglycemia\" title=\"Hyperglycemia\">hyperglycemia</a> but is unclear whether they add to the risk of developing <a href=\"/wiki/Gestational_diabetes\" title=\"Gestational diabetes\">gestational diabetes</a>.<sup id=\"cite_ref-aidsinfo2012_1-5\" class=\"reference\"><a href=\"#cite_note-aidsinfo2012-1\">&#91;1&#93;</a></sup> Some PIs have been noted to cause <a href=\"/wiki/Hyperbilirubinemia\" class=\"mw-redirect\" title=\"Hyperbilirubinemia\">hyperbilirubinemia</a> and nausea, so these side effects should be monitored for closely.</li>\n<li><a href=\"/wiki/Integrase_inhibitor\" title=\"Integrase inhibitor\">Integrase inhibitors</a> (IIs) are generally the third drug in the regimen when a PI cannot be used. They rapidly reduce the viral load and for this reason, they are often used in women who are diagnosed with HIV late in their pregnancy. <a href=\"/wiki/Raltegravir\" title=\"Raltegravir\">Raltegravir</a> (RAL) is the most common used.</li>\n<li><a href=\"/wiki/Non-nucleoside_reverse_transcriptase_inhibitor\" class=\"mw-redirect\" title=\"Non-nucleoside reverse transcriptase inhibitor\">Non-nucleoside reverse transcriptase inhibitors</a> (NNRTIs), the most popular being <a href=\"/wiki/Efavirenz\" title=\"Efavirenz\">efavirenz</a> (EFV) and <a href=\"/wiki/Nevirapine\" title=\"Nevirapine\">nevirapine</a> (NVP), may be used during pregnancy. However, there are significant toxicities associated with their use, making them a less desirable option.\n<ul><li><a href=\"/wiki/Efavirenz\" title=\"Efavirenz\">Efavirenz</a> (<a href=\"/wiki/Brand_name\" class=\"mw-redirect\" title=\"Brand name\">brand name</a> Sustiva, shortened as EFV, and a component of the combination drug <a href=\"/wiki/Atripla\" class=\"mw-redirect\" title=\"Atripla\">Atripla</a>) is classified as a <a href=\"/wiki/Pregnancy_category\" title=\"Pregnancy category\">category D</a> drug by the US <a href=\"/wiki/Food_and_Drug_Administration\" title=\"Food and Drug Administration\">Food and Drug Administration</a> indicating there are risks associated with its use during pregnancy. In a study analyzing the use of the drug in pregnant women, 2.3% of births were associated with birth defects.<sup id=\"cite_ref-31\" class=\"reference\"><a href=\"#cite_note-31\">&#91;31&#93;</a></sup> However, a systematic review of the safety of EFV use in humans during the first trimester found no increase in birth defects among women using the drug.<sup id=\"cite_ref-:6_32-0\" class=\"reference\"><a href=\"#cite_note-:6-32\">&#91;32&#93;</a></sup> Given the uncertain potential for risk, the U.S. DHHS recommends against using EFV in the first trimester of pregnancy or in women who may become pregnant. They instead recommend a protease inhibitor based regimen with <a href=\"/wiki/Lopinavir\" title=\"Lopinavir\">lopinavir</a> (LPV) or ATV.<sup id=\"cite_ref-lvguidelines_12-5\" class=\"reference\"><a href=\"#cite_note-lvguidelines-12\">&#91;12&#93;</a></sup> However, to simplify regimens and provide a uniform recommendation for HIV-infected individuals during pregnancy, the WHO continues to recommend efavirenz as a first line agent for HIV positive women.<sup id=\"cite_ref-who2013_33-0\" class=\"reference\"><a href=\"#cite_note-who2013-33\">&#91;33&#93;</a></sup> Women using EFV prior to their pregnancy may continue with the drug as it is more dangerous to stop or change medications during pregnancy because this can result in improper control of the viral load.<sup id=\"cite_ref-:6_32-1\" class=\"reference\"><a href=\"#cite_note-:6-32\">&#91;32&#93;</a></sup></li>\n<li><a href=\"/wiki/Nevirapine\" title=\"Nevirapine\">Nevirapine</a> (<a href=\"/wiki/Trade_name\" title=\"Trade name\">trade name</a> Viramune, and shortened NVP) increases the risk of very serious liver damage in women with CD4 counts greater than 250 cells/mm<sup>3</sup> . It is generally avoided in pregnant women. Women taking NVP safely prior to pregnancy may continue with the medication because NVP-related liver damage has not been seen in women previously using the medication.<sup id=\"cite_ref-aidsinfo2012_1-6\" class=\"reference\"><a href=\"#cite_note-aidsinfo2012-1\">&#91;1&#93;</a></sup></li></ul></li></ul>\n<h3><span class=\"mw-headline\" id=\"Nutritional_supplements\">Nutritional supplements</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=HIV_and_pregnancy&amp;action=edit&amp;section=6\" title=\"Edit section: Nutritional supplements\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p><a href=\"/wiki/Vitamin_A\" title=\"Vitamin A\">Vitamin A</a> plays a role in the <a href=\"/wiki/Immune_system\" title=\"Immune system\">immune system</a> and is a low-cost intervention that has been suggested to help with preventing mother-to-child transmission of HIV. A Cochrane review<sup id=\"cite_ref-34\" class=\"reference\"><a href=\"#cite_note-34\">&#91;34&#93;</a></sup> summarised the evidence of five trials conducted in Malawi, South Africa, Tanzania and Zimbabwe between 1995 and 2005, where none of the participants received <a href=\"/wiki/Antiretroviral_therapy\" class=\"mw-redirect\" title=\"Antiretroviral therapy\">antiretroviral therapy</a>. They found that giving vitamin A supplementation to pregnant women or to women after they delivered a baby probably has little or no effect on mother-to-child transmission of HIV. The intervention has been largely superseded by antiretroviral therapy.\n</p>\n<h3><span class=\"mw-headline\" id=\"Labor_and_delivery\">Labor and delivery</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=HIV_and_pregnancy&amp;action=edit&amp;section=7\" title=\"Edit section: Labor and delivery\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>Women should continue their ART regimen through childbirth.\n</p><p>The viral load helps determine which mode of delivery is safest for the mother and the baby. In cases where the viral load is low (&lt;1000 copies/mL), the risk of transmission is low and a vaginal delivery may be performed. A cesarean section, on the other hand, is generally performed at 38 weeks gestation under the following circumstances:<sup id=\"cite_ref-:8_35-0\" class=\"reference\"><a href=\"#cite_note-:8-35\">&#91;35&#93;</a></sup>\n</p>\n<ul><li>Viral load is high (&gt;1000 copies/mL) or unknown at the time of delivery</li>\n<li>Mother did not receive ART during the pregnancy</li>\n<li>Mother is concerned about exposing her child to infected blood and genital secretions during the delivery</li></ul>\n<p>If, before her scheduled cesarean section, a woman's <a href=\"/wiki/Rupture_of_membranes\" title=\"Rupture of membranes\">water breaks</a> and she goes into labor, a cesarean section may not significantly reduce the risk of infection transmission. Under this circumstance, if there is no other medical reason to proceed with a cesarean section, a vaginal delivery may be performed and may be the safest for the mother and the baby.<sup id=\"cite_ref-aidsinfo2012_1-7\" class=\"reference\"><a href=\"#cite_note-aidsinfo2012-1\">&#91;1&#93;</a></sup>\n</p><p>Women who present to the hospital in labor with an unknown HIV status should undergo immediate HIV testing. If the initial screening test is positive, the mother should immediately be given a single dose of nifedipine (NVD), tenofovir (TDF) and emtricitabine (FTC) and a three-hourly dose of zidovudine (AZT) and the baby should receive prophylactic ART after birth. This will help reduce the risk of HIV transmission during labor and delivery. A confirmatory HIV test should also be performed in the meantime. If the test results are positive, treatment should continue. If the results are negative, the medications may be stopped.<sup id=\"cite_ref-:10_28-1\" class=\"reference\"><a href=\"#cite_note-:10-28\">&#91;28&#93;</a></sup><sup id=\"cite_ref-:8_35-1\" class=\"reference\"><a href=\"#cite_note-:8-35\">&#91;35&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Breastfeeding\">Breastfeeding</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=HIV_and_pregnancy&amp;action=edit&amp;section=8\" title=\"Edit section: Breastfeeding\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>Women may transmit HIV to their child via <a href=\"/wiki/Breast_milk\" title=\"Breast milk\">breastmilk</a>. For this reason, <a href=\"/wiki/Breastfeeding\" title=\"Breastfeeding\">breastfeeding</a> is discouraged in the United States amongst HIV-positive women.<sup id=\"cite_ref-aidsinfo2012_1-8\" class=\"reference\"><a href=\"#cite_note-aidsinfo2012-1\">&#91;1&#93;</a></sup> However, in <a href=\"/wiki/Developing_countries\" class=\"mw-redirect\" title=\"Developing countries\">developing countries</a> such as <a href=\"/wiki/South_Africa\" title=\"South Africa\">South Africa</a>, where the risk of death of the infant associated with avoiding <a href=\"/w/index.php?title=Exclusive_breastfeeding&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Exclusive breastfeeding (page does not exist)\">exclusive breastfeeding</a> is higher than the risk of contracting HIV, exclusive breastfeeding in a mother who is virally suppressed is encouraged.<sup id=\"cite_ref-:9_2-1\" class=\"reference\"><a href=\"#cite_note-:9-2\">&#91;2&#93;</a></sup> \n</p><p>In <a href=\"/wiki/Developed_countries\" class=\"mw-redirect\" title=\"Developed countries\">developed countries</a>, where clean water and infant formula are both accessible and available, HIV-positive women should not breastfeed. They should use formula to reduce the risk of transmitting HIV to the child. Even if the mother is on ART, she should avoid breastfeeding as HIV can still be transmitted through the breastmilk. Some women elect to use <a href=\"/wiki/Human_milk_banking_in_North_America\" title=\"Human milk banking in North America\">donor milk</a> (breast milk donated from non-HIV infected mothers) instead of formula so that their child may receive the health benefits of breast milk, the most notable being increased immunity.<sup id=\"cite_ref-36\" class=\"reference\"><a href=\"#cite_note-36\">&#91;36&#93;</a></sup>\n</p><p>In underdeveloped countries, where clean water and formula are not as readily available, breastfeeding is encouraged to provide the child with adequate food and nutrients. The benefit of nourishment outweighs the risk of HIV transmission so breastfeeding is acceptable.<sup id=\"cite_ref-who2013_33-1\" class=\"reference\"><a href=\"#cite_note-who2013-33\">&#91;33&#93;</a></sup> The <a href=\"/wiki/South_African_Department_of_Health\" class=\"mw-redirect\" title=\"South African Department of Health\">South African Department of Health</a> guidelines state that HIV-infected mothers should exclusively breastfeed, that is the infant's diet should consist of breastmilk only and should not be supplemented with water, other liquids or foods, for 6 months after birth. After 6 months, the mother should introduce complementary foods while continuing to breastfeed for up to 24 months.<sup id=\"cite_ref-:10_28-2\" class=\"reference\"><a href=\"#cite_note-:10-28\">&#91;28&#93;</a></sup><sup id=\"cite_ref-:9_2-2\" class=\"reference\"><a href=\"#cite_note-:9-2\">&#91;2&#93;</a></sup><sup>:7</sup> \n</p><p>In a study conducted in South Africa, 1.1% of children born to HIV-infected mothers who were uninfected at 6 weeks of age, were infected within 1 month of breastfeeding and 4.0% were infected by 6 months of age.<sup id=\"cite_ref-pmid17398310_37-0\" class=\"reference\"><a href=\"#cite_note-pmid17398310-37\">&#91;37&#93;</a></sup> A study in Malawi found that the risk of HIV transmission through breastfeeding was 7% in children who breastfed for one year and 10% in children who breastfed for two years. The risk of HIV infection appears to be highest in the early months of breastfeeding and HIV-infected mothers who are not virally suppressed should avoid breastfeeding entirely if possible.<sup id=\"cite_ref-pmid10463709_38-0\" class=\"reference\"><a href=\"#cite_note-pmid10463709-38\">&#91;38&#93;</a></sup> In contrast, a systematic review commissioned by the WHO found that there is a very low risk (1.1%) of postnatal HIV transmission in infants breastfed by mothers on lifelong ART that was initiated in early to mid pregnancy. The overall risk of transmission was 3.3%, including exposures <i>in utero</i> and during childbirth.<sup id=\"cite_ref-39\" class=\"reference\"><a href=\"#cite_note-39\">&#91;39&#93;</a></sup> Another systematic review found that prolonged breastfeeding for infants born to mothers on lifelong ART is beneficial in terms of HIV\u2010free survival at least up to 24 months of age \u2013 increasing HIV-free survival rates from 89% to 96%.<sup id=\"cite_ref-40\" class=\"reference\"><a href=\"#cite_note-40\">&#91;40&#93;</a></sup>\n</p><p>If the mother has a high HIV <a href=\"/wiki/Viral_load\" title=\"Viral load\">viral load</a> (&gt;1000 copies/L), replacement feeding, such as formula, is only initiated as per the <a href=\"/wiki/UNAIDS\" class=\"mw-redirect\" title=\"UNAIDS\">UNAIDS</a> guidelines, termed the AFASS criteria, \"where replacement feeding is acceptable, feasible, affordable, sustainable, and safe.\"<sup id=\"cite_ref-41\" class=\"reference\"><a href=\"#cite_note-41\">&#91;41&#93;</a></sup><sup id=\"cite_ref-:10_28-3\" class=\"reference\"><a href=\"#cite_note-:10-28\">&#91;28&#93;</a></sup><sup>:95-6</sup> A mother may only be given infant formula, as explained by the WHO, if the following conditions are met:<sup id=\"cite_ref-:9_2-3\" class=\"reference\"><a href=\"#cite_note-:9-2\">&#91;2&#93;</a></sup>\n</p>\n<ul><li>\"Safe water and sanitation are assured at the household level and in the community; and</li>\n<li>the mother or other caregiver can reliably provide sufficient infant formula milk to support the normal growth and development of the infant; and</li>\n<li>the mother or caregiver can prepare it cleanly and frequently enough so that it is safe and carries a low risk of diarrhoea and malnutrition; and</li>\n<li>the mother or caregiver can exclusively give infant formula milk in the first six months; and</li>\n<li>the family is supportive of this practice; and</li>\n<li>the mother or caregiver can access health care that offers comprehensive child health services.\"</li></ul>\n<h2><span class=\"mw-headline\" id=\"Other_considerations_during_pregnancy\">Other considerations during pregnancy</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=HIV_and_pregnancy&amp;action=edit&amp;section=9\" title=\"Edit section: Other considerations during pregnancy\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>Pregnant women with HIV may still receive the trivalent inactivated <a href=\"/wiki/Influenza_vaccine\" title=\"Influenza vaccine\">influenza vaccine</a> and the tetanus, diphtheria, and pertussis (Tdap) vaccination during pregnancy.<sup id=\"cite_ref-MadhiCutland2014_42-0\" class=\"reference\"><a href=\"#cite_note-MadhiCutland2014-42\">&#91;42&#93;</a></sup>\n</p><p>Many patients who are HIV positive also have other health conditions known as <a href=\"/wiki/Comorbidity\" title=\"Comorbidity\">comorbidities</a>. Hepatitis B, hepatitis C, tuberculosis and injection drug use are some of the most common comorbidities associated with HIV. Women who screen positive for HIV should also be tested for these conditions so that they may be adequately treated or controlled during the pregnancy. The comorbidities may have serious adverse effects on the mother and child during pregnancy, so it is extremely important to identify them early during the pregnancy.<sup id=\"cite_ref-43\" class=\"reference\"><a href=\"#cite_note-43\">&#91;43&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Postnatal_care\">Postnatal care</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=HIV_and_pregnancy&amp;action=edit&amp;section=10\" title=\"Edit section: Postnatal care\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>Babies born to HIV-positive women should receive a 6-week or 12-week course of zidovudine (AZT). The medication should ideally be started within the first 6 to 12 hours of life, but can be started up to 72 hours after birth.<sup id=\"cite_ref-:10_28-4\" class=\"reference\"><a href=\"#cite_note-:10-28\">&#91;28&#93;</a></sup> A 6-week course should be initiated if the mother has been on ART for more than four weeks before birth, and a 12-week course should be initiated if the mother is newly diagnosed or has been on ART for less than four weeks before birth.<sup id=\"cite_ref-:10_28-5\" class=\"reference\"><a href=\"#cite_note-:10-28\">&#91;28&#93;</a></sup> The baby should be tested for HIV at birth, 4 weeks after cessation of AZT (10 weeks or 16 weeks, depending on length of AZT course, after birth), 6 weeks after cessation of breastfeeding and at 18 months.<sup id=\"cite_ref-:10_28-6\" class=\"reference\"><a href=\"#cite_note-:10-28\">&#91;28&#93;</a></sup> Usual antibody based testing is unreliable in infants until the age of 18 months due to the transmission of <a href=\"/wiki/Maternal_antibodies\" class=\"mw-redirect\" title=\"Maternal antibodies\">maternal antibodies</a>. A qualitative HIV <a href=\"/wiki/DNA\" title=\"DNA\">DNA</a> <a href=\"/wiki/Polymerase_chain_reaction\" title=\"Polymerase chain reaction\">PCR</a> assay is recommended as it will detect pro-viral HIV DNA since HIV RNA may be suppressed by ART.<sup id=\"cite_ref-44\" class=\"reference\"><a href=\"#cite_note-44\">&#91;44&#93;</a></sup> In order to ensure the baby is HIV-negative, there must be two negative test results. Since zidovudine has been known to cause or worsen anemia, the baby's blood count should be routinely checked during AZT therapy.<sup id=\"cite_ref-45\" class=\"reference\"><a href=\"#cite_note-45\">&#91;45&#93;</a></sup>\n</p><p>To reduce the risk of developing <i><a href=\"/wiki/Pneumocystis_pneumonia\" title=\"Pneumocystis pneumonia\">Pneumocystis jirovecii</a></i> <a href=\"/wiki/Pneumocystis_pneumonia\" title=\"Pneumocystis pneumonia\">pneumonia</a> (PJP), all infants born to HIV-positive mothers should receive <a href=\"/wiki/Trimethoprim/sulfamethoxazole\" title=\"Trimethoprim/sulfamethoxazole\">trimethoprim/sulfamethoxazole</a> (cotrimoxazole) from 4\u20136 weeks after birth, and stop prophylaxis when they are no longer at risk of contracting HIV from their mother.<sup id=\"cite_ref-:10_28-7\" class=\"reference\"><a href=\"#cite_note-:10-28\">&#91;28&#93;</a></sup>\n</p><p>Although the risk is very low, HIV can also be transmitted to a baby through food that was previously chewed (pre-chewed) by a mother or caretaker infected with HIV. To be safe, babies should not be fed pre-chewed food.<sup id=\"cite_ref-aidsinfo2012_1-9\" class=\"reference\"><a href=\"#cite_note-aidsinfo2012-1\">&#91;1&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"References\">References</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=HIV_and_pregnancy&amp;action=edit&amp;section=11\" title=\"Edit section: References\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<div class=\"reflist\" style=\"list-style-type: decimal;\">\n<div class=\"mw-references-wrap mw-references-columns\"><ol class=\"references\">\n<li id=\"cite_note-aidsinfo2012-1\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-aidsinfo2012_1-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-aidsinfo2012_1-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-aidsinfo2012_1-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-aidsinfo2012_1-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-aidsinfo2012_1-4\"><sup><i><b>e</b></i></sup></a> <a href=\"#cite_ref-aidsinfo2012_1-5\"><sup><i><b>f</b></i></sup></a> <a href=\"#cite_ref-aidsinfo2012_1-6\"><sup><i><b>g</b></i></sup></a> <a href=\"#cite_ref-aidsinfo2012_1-7\"><sup><i><b>h</b></i></sup></a> <a href=\"#cite_ref-aidsinfo2012_1-8\"><sup><i><b>i</b></i></sup></a> <a href=\"#cite_ref-aidsinfo2012_1-9\"><sup><i><b>j</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web\">(HHS) Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission, a working group of the <i>Office of AIDS Research Advisory Council</i> (OARAC). <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20150421024106/http://aidsinfo.nih.gov/contentfiles/perinatal_FS_en.pdf\">\"HIV and Pregnancy\"</a> <span style=\"font-size:85%;\">(PDF)</span>. <i>aidsinfo.nih.gov</i>. U.S. Department of Health and Human Services. Archived from <a rel=\"nofollow\" class=\"external text\" href=\"http://aidsinfo.nih.gov/contentfiles/perinatal_FS_en.pdf\">the original</a> <span style=\"font-size:85%;\">(PDF)</span> on 21 April 2015<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">1 August</span> 2015</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=aidsinfo.nih.gov&amp;rft.atitle=HIV+and+Pregnancy&amp;rft_id=http%3A%2F%2Faidsinfo.nih.gov%2Fcontentfiles%2Fperinatal_FS_en.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHIV+and+pregnancy\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span><span class=\"citation-comment\" style=\"display:none; color:#33aa33; margin-left:0.3em\">CS1 maint: Uses authors parameter (<a href=\"/wiki/Category:CS1_maint:_Uses_authors_parameter\" title=\"Category:CS1 maint: Uses authors parameter\">link</a>) </span></span>\n</li>\n<li id=\"cite_note-:9-2\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-:9_2-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-:9_2-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-:9_2-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-:9_2-3\"><sup><i><b>d</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation book\"><a rel=\"nofollow\" class=\"external text\" href=\"http://apps.who.int/iris/bitstream/handle/10665/246260/9789241549707-eng.pdf?sequence=1\"><i>Guideline: Updates on HIV and infant feeding</i></a> <span style=\"font-size:85%;\">(PDF)</span>. World Health Organisation, UNICEF. 2016.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Guideline%3A+Updates+on+HIV+and+infant+feeding&amp;rft.pub=World+Health+Organisation%2C+UNICEF&amp;rft.date=2016&amp;rft_id=http%3A%2F%2Fapps.who.int%2Firis%2Fbitstream%2Fhandle%2F10665%2F246260%2F9789241549707-eng.pdf%3Fsequence%3D1&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHIV+and+pregnancy\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Mother2010-3\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Mother2010_3-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Coutsoudis A, Kwaan L, Thomson M (October 2010). \"Prevention of vertical transmission of HIV-1 in resource-limited settings\". <i>Expert Review of Anti-Infective Therapy</i>. <b>8</b> (10): 1163\u201375. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1586/eri.10.94\">10.1586/eri.10.94</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/20954881\">20954881</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Expert+Review+of+Anti-Infective+Therapy&amp;rft.atitle=Prevention+of+vertical+transmission+of+HIV-1+in+resource-limited+settings&amp;rft.volume=8&amp;rft.issue=10&amp;rft.pages=1163-75&amp;rft.date=2010-10&amp;rft_id=info%3Adoi%2F10.1586%2Feri.10.94&amp;rft_id=info%3Apmid%2F20954881&amp;rft.aulast=Coutsoudis&amp;rft.aufirst=A&amp;rft.au=Kwaan%2C+L&amp;rft.au=Thomson%2C+M&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHIV+and+pregnancy\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-4\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-4\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.who.int/hiv/topics/mtct/en/\">\"Mother-to-child transmission of HIV\"</a>. <i>World Health Organization</i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2015-11-18</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=World+Health+Organization&amp;rft.atitle=Mother-to-child+transmission+of+HIV&amp;rft_id=http%3A%2F%2Fwww.who.int%2Fhiv%2Ftopics%2Fmtct%2Fen%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHIV+and+pregnancy\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-5\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-5\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://apps.who.int/iris/bitstream/10665/82207/1/WHO_RHR_13.02_eng.pdf\">\"Sexually Transmitted Infections (STIs)\"</a> <span style=\"font-size:85%;\">(PDF)</span>. World Health Organization. 2013.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Sexually+Transmitted+Infections+%28STIs%29&amp;rft.pub=World+Health+Organization&amp;rft.date=2013&amp;rft_id=http%3A%2F%2Fapps.who.int%2Firis%2Fbitstream%2F10665%2F82207%2F1%2FWHO_RHR_13.02_eng.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHIV+and+pregnancy\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-6\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-6\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation book\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.unaids.org/sites/default/files/media_asset/09_ChildrenandpregnantwomenlivingwithHIV.pdf\"><i>Children and Pregnant Women Living with HIV</i></a> <span style=\"font-size:85%;\">(PDF)</span>. UNAIDS. 2014. <a href=\"/wiki/International_Standard_Book_Number\" title=\"International Standard Book Number\">ISBN</a>&#160;<a href=\"/wiki/Special:BookSources/978-92-9253-062-4\" title=\"Special:BookSources/978-92-9253-062-4\">978-92-9253-062-4</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Children+and+Pregnant+Women+Living+with+HIV&amp;rft.pub=UNAIDS&amp;rft.date=2014&amp;rft.isbn=978-92-9253-062-4&amp;rft_id=http%3A%2F%2Fwww.unaids.org%2Fsites%2Fdefault%2Ffiles%2Fmedia_asset%2F09_ChildrenandpregnantwomenlivingwithHIV.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHIV+and+pregnancy\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-7\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-7\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.who.int/bulletin/volumes/91/1/12-106807/en/\">\"WHO | Eliminating mother-to-child HIV transmission in South Africa\"</a>. <i>www.who.int</i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2015-11-20</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=www.who.int&amp;rft.atitle=WHO+%7C+Eliminating+mother-to-child+HIV+transmission+in+South+Africa&amp;rft_id=http%3A%2F%2Fwww.who.int%2Fbulletin%2Fvolumes%2F91%2F1%2F12-106807%2Fen%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHIV+and+pregnancy\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-:3-8\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-:3_8-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.who.int/mediacentre/news/releases/2015/mtct-hiv-cuba/en/\">\"WHO validates elimination of mother-to-child transmission of HIV and syphilis in Cuba\"</a>. <a href=\"/wiki/WHO\" class=\"mw-redirect\" title=\"WHO\">WHO</a>. 30 June 2015<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">30 Aug</span> 2015</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=WHO+validates+elimination+of+mother-to-child+transmission+of+HIV+and+syphilis+in+Cuba&amp;rft.pub=WHO&amp;rft.date=2015-06-30&amp;rft_id=http%3A%2F%2Fwww.who.int%2Fmediacentre%2Fnews%2Freleases%2F2015%2Fmtct-hiv-cuba%2Fen%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHIV+and+pregnancy\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-:0-9\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-:0_9-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-:0_9-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">van Leeuwen E, Prins JM, Jurriaans S, Boer K, Reiss P, Repping S, van der Veen F (2007-03-01). \"Reproduction and fertility in human immunodeficiency virus type-1 infection\". <i>Human Reproduction Update</i>. <b>13</b> (2): 197\u2013206. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1093/humupd/dml052\">10.1093/humupd/dml052</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/17099206\">17099206</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Human+Reproduction+Update&amp;rft.atitle=Reproduction+and+fertility+in+human+immunodeficiency+virus+type-1+infection&amp;rft.volume=13&amp;rft.issue=2&amp;rft.pages=197-206&amp;rft.date=2007-03-01&amp;rft_id=info%3Adoi%2F10.1093%2Fhumupd%2Fdml052&amp;rft_id=info%3Apmid%2F17099206&amp;rft.aulast=van+Leeuwen&amp;rft.aufirst=E&amp;rft.au=Prins%2C+JM&amp;rft.au=Jurriaans%2C+S&amp;rft.au=Boer%2C+K&amp;rft.au=Reiss%2C+P&amp;rft.au=Repping%2C+S&amp;rft.au=van+der+Veen%2C+F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHIV+and+pregnancy\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-10\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-10\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N,  et al. (August 2011). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3200068\">\"Prevention of HIV-1 infection with early antiretroviral therapy\"</a>. <i>The New England Journal of Medicine</i>. <b>365</b> (6): 493\u2013505. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1056/NEJMoa1105243\">10.1056/NEJMoa1105243</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3200068\">3200068</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/21767103\">21767103</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+England+Journal+of+Medicine&amp;rft.atitle=Prevention+of+HIV-1+infection+with+early+antiretroviral+therapy&amp;rft.volume=365&amp;rft.issue=6&amp;rft.pages=493-505&amp;rft.date=2011-08&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3200068&amp;rft_id=info%3Apmid%2F21767103&amp;rft_id=info%3Adoi%2F10.1056%2FNEJMoa1105243&amp;rft.aulast=Cohen&amp;rft.aufirst=MS&amp;rft.au=Chen%2C+YQ&amp;rft.au=McCauley%2C+M&amp;rft.au=Gamble%2C+T&amp;rft.au=Hosseinipour%2C+MC&amp;rft.au=Kumarasamy%2C+N&amp;rft.au=Hakim%2C+JG&amp;rft.au=Kumwenda%2C+J&amp;rft.au=Grinsztejn%2C+B&amp;rft.au=Pilotto%2C+JH&amp;rft.au=Godbole%2C+SV&amp;rft.au=Mehendale%2C+S&amp;rft.au=Chariyalertsak%2C+S&amp;rft.au=Santos%2C+BR&amp;rft.au=Mayer%2C+KH&amp;rft.au=Hoffman%2C+IF&amp;rft.au=Eshleman%2C+SH&amp;rft.au=Piwowar-Manning%2C+E&amp;rft.au=Wang%2C+L&amp;rft.au=Makhema%2C+J&amp;rft.au=Mills%2C+LA&amp;rft.au=de+Bruyn%2C+G&amp;rft.au=Sanne%2C+I&amp;rft.au=Eron%2C+J&amp;rft.au=Gallant%2C+J&amp;rft.au=Havlir%2C+D&amp;rft.au=Swindells%2C+S&amp;rft.au=Ribaudo%2C+H&amp;rft.au=Elharrar%2C+V&amp;rft.au=Burns%2C+D&amp;rft.au=Taha%2C+TE&amp;rft.au=Nielsen-Saines%2C+K&amp;rft.au=Celentano%2C+D&amp;rft.au=Essex%2C+M&amp;rft.au=Fleming%2C+TR&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3200068&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHIV+and+pregnancy\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Savasi2013-11\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Savasi2013_11-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Savasi2013_11-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Savasi V, Mandia L, Laoreti A, Cetin I (2012). \"Reproductive assistance in HIV serodiscordant couples\". <i>Human Reproduction Update</i>. <b>19</b> (2): 136\u201350. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1093/humupd/dms046\">10.1093/humupd/dms046</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/23146867\">23146867</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Human+Reproduction+Update&amp;rft.atitle=Reproductive+assistance+in+HIV+serodiscordant+couples&amp;rft.volume=19&amp;rft.issue=2&amp;rft.pages=136-50&amp;rft.date=2012&amp;rft_id=info%3Adoi%2F10.1093%2Fhumupd%2Fdms046&amp;rft_id=info%3Apmid%2F23146867&amp;rft.aulast=Savasi&amp;rft.aufirst=V&amp;rft.au=Mandia%2C+L&amp;rft.au=Laoreti%2C+A&amp;rft.au=Cetin%2C+I&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHIV+and+pregnancy\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-lvguidelines-12\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-lvguidelines_12-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-lvguidelines_12-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-lvguidelines_12-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-lvguidelines_12-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-lvguidelines_12-4\"><sup><i><b>e</b></i></sup></a> <a href=\"#cite_ref-lvguidelines_12-5\"><sup><i><b>f</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web\">Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission. <a rel=\"nofollow\" class=\"external text\" href=\"http://aidsinfo.nih.gov/contentfiles/lvguidelines/PerinatalGL.pdf\">\"Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV Transmission in the United States\"</a> <span style=\"font-size:85%;\">(PDF)</span><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">20 November</span> 2015</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Recommendations+for+Use+of+Antiretroviral+Drugs+in+Pregnant+HIV-1-Infected+Women+for+Maternal+Health+and+Interventions+to+Reduce+Perinatal+HIV+Transmission+in+the+United+States&amp;rft.au=Panel+on+Treatment+of+HIV-Infected+Pregnant+Women+and+Prevention+of+Perinatal+Transmission.&amp;rft_id=http%3A%2F%2Faidsinfo.nih.gov%2Fcontentfiles%2Flvguidelines%2FPerinatalGL.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHIV+and+pregnancy\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-13\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-13\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N,  et al. (August 2011). <a rel=\"nofollow\" class=\"external text\" href=\"http://nrs.harvard.edu/urn-3:HUL.InstRepos:26667502\">\"Prevention of HIV-1 infection with early antiretroviral therapy\"</a>. <i>The New England Journal of Medicine</i>. <b>365</b> (6): 493\u2013505. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1056/NEJMoa1105243\">10.1056/NEJMoa1105243</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3200068\">3200068</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/21767103\">21767103</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+England+Journal+of+Medicine&amp;rft.atitle=Prevention+of+HIV-1+infection+with+early+antiretroviral+therapy&amp;rft.volume=365&amp;rft.issue=6&amp;rft.pages=493-505&amp;rft.date=2011-08&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3200068&amp;rft_id=info%3Apmid%2F21767103&amp;rft_id=info%3Adoi%2F10.1056%2FNEJMoa1105243&amp;rft.aulast=Cohen&amp;rft.aufirst=MS&amp;rft.au=Chen%2C+YQ&amp;rft.au=McCauley%2C+M&amp;rft.au=Gamble%2C+T&amp;rft.au=Hosseinipour%2C+MC&amp;rft.au=Kumarasamy%2C+N&amp;rft.au=Hakim%2C+JG&amp;rft.au=Kumwenda%2C+J&amp;rft.au=Grinsztejn%2C+B&amp;rft.au=Pilotto%2C+JH&amp;rft.au=Godbole%2C+SV&amp;rft.au=Mehendale%2C+S&amp;rft.au=Chariyalertsak%2C+S&amp;rft.au=Santos%2C+BR&amp;rft.au=Mayer%2C+KH&amp;rft.au=Hoffman%2C+IF&amp;rft.au=Eshleman%2C+SH&amp;rft.au=Piwowar-Manning%2C+E&amp;rft.au=Wang%2C+L&amp;rft.au=Makhema%2C+J&amp;rft.au=Mills%2C+LA&amp;rft.au=de+Bruyn%2C+G&amp;rft.au=Sanne%2C+I&amp;rft.au=Eron%2C+J&amp;rft.au=Gallant%2C+J&amp;rft.au=Havlir%2C+D&amp;rft.au=Swindells%2C+S&amp;rft.au=Ribaudo%2C+H&amp;rft.au=Elharrar%2C+V&amp;rft.au=Burns%2C+D&amp;rft.au=Taha%2C+TE&amp;rft.au=Nielsen-Saines%2C+K&amp;rft.au=Celentano%2C+D&amp;rft.au=Essex%2C+M&amp;rft.au=Fleming%2C+TR&amp;rft_id=http%3A%2F%2Fnrs.harvard.edu%2Furn-3%3AHUL.InstRepos%3A26667502&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHIV+and+pregnancy\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-14\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-14\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Thigpen MC, Kebaabetswe PM, Paxton LA, Smith DK, Rose CE, Segolodi TM,  et al. (August 2012). \"Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana\". <i>The New England Journal of Medicine</i>. <b>367</b> (5): 423\u201334. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1056/NEJMoa1110711\">10.1056/NEJMoa1110711</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/22784038\">22784038</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+England+Journal+of+Medicine&amp;rft.atitle=Antiretroviral+preexposure+prophylaxis+for+heterosexual+HIV+transmission+in+Botswana&amp;rft.volume=367&amp;rft.issue=5&amp;rft.pages=423-34&amp;rft.date=2012-08&amp;rft_id=info%3Adoi%2F10.1056%2FNEJMoa1110711&amp;rft_id=info%3Apmid%2F22784038&amp;rft.aulast=Thigpen&amp;rft.aufirst=MC&amp;rft.au=Kebaabetswe%2C+PM&amp;rft.au=Paxton%2C+LA&amp;rft.au=Smith%2C+DK&amp;rft.au=Rose%2C+CE&amp;rft.au=Segolodi%2C+TM&amp;rft.au=Henderson%2C+FL&amp;rft.au=Pathak%2C+SR&amp;rft.au=Soud%2C+FA&amp;rft.au=Chillag%2C+KL&amp;rft.au=Mutanhaurwa%2C+R&amp;rft.au=Chirwa%2C+LI&amp;rft.au=Kasonde%2C+M&amp;rft.au=Abebe%2C+D&amp;rft.au=Buliva%2C+E&amp;rft.au=Gvetadze%2C+RJ&amp;rft.au=Johnson%2C+S&amp;rft.au=Sukalac%2C+T&amp;rft.au=Thomas%2C+VT&amp;rft.au=Hart%2C+C&amp;rft.au=Johnson%2C+JA&amp;rft.au=Malotte%2C+CK&amp;rft.au=Hendrix%2C+CW&amp;rft.au=Brooks%2C+JT&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHIV+and+pregnancy\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-15\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-15\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Glynn JR, Buv\u00e9 A, Cara\u00ebl M, Kahindo M, Macauley IB, Musonda RM, Jungmann E, Tembo F, Zekeng L (December 2000). \"Decreased fertility among HIV-1-infected women attending antenatal clinics in three African cities\". <i>Journal of Acquired Immune Deficiency Syndromes</i>. <b>25</b> (4): 345\u201352. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1097/00126334-200012010-00008\">10.1097/00126334-200012010-00008</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/11114835\">11114835</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Acquired+Immune+Deficiency+Syndromes&amp;rft.atitle=Decreased+fertility+among+HIV-1-infected+women+attending+antenatal+clinics+in+three+African+cities&amp;rft.volume=25&amp;rft.issue=4&amp;rft.pages=345-52&amp;rft.date=2000-12&amp;rft_id=info%3Adoi%2F10.1097%2F00126334-200012010-00008&amp;rft_id=info%3Apmid%2F11114835&amp;rft.aulast=Glynn&amp;rft.aufirst=JR&amp;rft.au=Buv%C3%A9%2C+A&amp;rft.au=Cara%C3%ABl%2C+M&amp;rft.au=Kahindo%2C+M&amp;rft.au=Macauley%2C+IB&amp;rft.au=Musonda%2C+RM&amp;rft.au=Jungmann%2C+E&amp;rft.au=Tembo%2C+F&amp;rft.au=Zekeng%2C+L&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHIV+and+pregnancy\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-16\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-16\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Kushnir VA, Lewis W (September 2011). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3165097\">\"Human immunodeficiency virus/acquired immunodeficiency syndrome and infertility: emerging problems in the era of highly active antiretrovirals\"</a>. <i>Fertility and Sterility</i>. <b>96</b> (3): 546\u201353. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.fertnstert.2011.05.094\">10.1016/j.fertnstert.2011.05.094</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3165097\">3165097</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/21722892\">21722892</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Fertility+and+Sterility&amp;rft.atitle=Human+immunodeficiency+virus%2Facquired+immunodeficiency+syndrome+and+infertility%3A+emerging+problems+in+the+era+of+highly+active+antiretrovirals&amp;rft.volume=96&amp;rft.issue=3&amp;rft.pages=546-53&amp;rft.date=2011-09&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3165097&amp;rft_id=info%3Apmid%2F21722892&amp;rft_id=info%3Adoi%2F10.1016%2Fj.fertnstert.2011.05.094&amp;rft.aulast=Kushnir&amp;rft.aufirst=VA&amp;rft.au=Lewis%2C+W&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3165097&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHIV+and+pregnancy\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-17\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-17\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">\"HIV-1 infection and artificial insemination with processed semen\". <i>MMWR. Morbidity and Mortality Weekly Report</i>. <b>39</b> (15): 249, 255\u20136. April 1990. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/2109169\">2109169</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=MMWR.+Morbidity+and+Mortality+Weekly+Report&amp;rft.atitle=HIV-1+infection+and+artificial+insemination+with+processed+semen&amp;rft.volume=39&amp;rft.issue=15&amp;rft.pages=249%2C+255-6&amp;rft.date=1990-04&amp;rft_id=info%3Apmid%2F2109169&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHIV+and+pregnancy\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-:1-18\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-:1_18-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-:1_18-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.cdc.gov/hiv/group/gender/pregnantwomen/opt-out.html\">\"Opt-Out| Pregnant Women, Infants, and Children | Gender | HIV by Group | HIV/AIDS | CDC\"</a>. <i>www.cdc.gov</i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2015-11-13</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=www.cdc.gov&amp;rft.atitle=Opt-Out%7C+Pregnant+Women%2C+Infants%2C+and+Children+%7C+Gender+%7C+HIV+by+Group+%7C+HIV%2FAIDS+%7C+CDC&amp;rft_id=https%3A%2F%2Fwww.cdc.gov%2Fhiv%2Fgroup%2Fgender%2Fpregnantwomen%2Fopt-out.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHIV+and+pregnancy\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-19\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-19\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"https://aidsinfo.nih.gov/contentfiles/hivtestingandpregnancy_fs_en.pdf\">\"Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV Transmission in the United States\"</a> <span style=\"font-size:85%;\">(PDF)</span>. U.S. Department of Health and Human Services (HHS)<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">1 February</span> 2012</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Recommendations+for+Use+of+Antiretroviral+Drugs+in+Pregnant+HIV-1-Infected+Women+for+Maternal+Health+and+Interventions+to+Reduce+Perinatal+HIV+Transmission+in+the+United+States.&amp;rft.pub=U.S.+Department+of+Health+and+Human+Services+%28HHS%29&amp;rft_id=https%3A%2F%2Faidsinfo.nih.gov%2Fcontentfiles%2Fhivtestingandpregnancy_fs_en.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHIV+and+pregnancy\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-:2-20\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-:2_20-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-:2_20-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Cornett JK, Kirn TJ (September 2013). \"Laboratory diagnosis of HIV in adults: a review of current methods\". <i>Clinical Infectious Diseases</i>. <b>57</b> (5): 712\u20138. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1093/cid/cit281\">10.1093/cid/cit281</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/23667267\">23667267</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Clinical+Infectious+Diseases&amp;rft.atitle=Laboratory+diagnosis+of+HIV+in+adults%3A+a+review+of+current+methods&amp;rft.volume=57&amp;rft.issue=5&amp;rft.pages=712-8&amp;rft.date=2013-09&amp;rft_id=info%3Adoi%2F10.1093%2Fcid%2Fcit281&amp;rft_id=info%3Apmid%2F23667267&amp;rft.aulast=Cornett&amp;rft.aufirst=JK&amp;rft.au=Kirn%2C+TJ&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHIV+and+pregnancy\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid23911678-21\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid23911678_21-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Masciotra S, Luo W, Youngpairoj AS, Kennedy MS, Wells S, Ambrose K,  et al. (December 2013). \"Performance of the Alere Determine\u2122 HIV-1/2 Ag/Ab Combo Rapid Test with specimens from HIV-1 seroconverters from the US and HIV-2 infected individuals from Ivory Coast\". <i>Journal of Clinical Virology&#160;: the Official Publication of the Pan American Society for Clinical Virology</i>. <b>58</b> (Suppl 1): e54\u20138. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.jcv.2013.07.002\">10.1016/j.jcv.2013.07.002</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/23911678\">23911678</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Clinical+Virology+%3A+the+Official+Publication+of+the+Pan+American+Society+for+Clinical+Virology&amp;rft.atitle=Performance+of+the+Alere+Determine%E2%84%A2+HIV-1%2F2+Ag%2FAb+Combo+Rapid+Test+with+specimens+from+HIV-1+seroconverters+from+the+US+and+HIV-2+infected+individuals+from+Ivory+Coast&amp;rft.volume=58&amp;rft.issue=Suppl+1&amp;rft.pages=e54-8&amp;rft.date=2013-12&amp;rft_id=info%3Adoi%2F10.1016%2Fj.jcv.2013.07.002&amp;rft_id=info%3Apmid%2F23911678&amp;rft.aulast=Masciotra&amp;rft.aufirst=S&amp;rft.au=Luo%2C+W&amp;rft.au=Youngpairoj%2C+AS&amp;rft.au=Kennedy%2C+MS&amp;rft.au=Wells%2C+S&amp;rft.au=Ambrose%2C+K&amp;rft.au=Sprinkle%2C+P&amp;rft.au=Owen%2C+SM&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHIV+and+pregnancy\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-22\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-22\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Minkoff H (April 2003). \"Human immunodeficiency virus infection in pregnancy\". <i>Obstetrics and Gynecology</i>. <b>101</b> (4): 797\u2013810. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1097/00006250-200304000-00038\">10.1097/00006250-200304000-00038</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/12681888\">12681888</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Obstetrics+and+Gynecology&amp;rft.atitle=Human+immunodeficiency+virus+infection+in+pregnancy&amp;rft.volume=101&amp;rft.issue=4&amp;rft.pages=797-810&amp;rft.date=2003-04&amp;rft_id=info%3Adoi%2F10.1097%2F00006250-200304000-00038&amp;rft_id=info%3Apmid%2F12681888&amp;rft.aulast=Minkoff&amp;rft.aufirst=H&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHIV+and+pregnancy\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-23\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-23\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Lee TH, Chafets DM, Biggar RJ, McCune JM, Busch MP (October 2010). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3509795\">\"The role of transplacental microtransfusions of maternal lymphocytes in in utero HIV transmission\"</a>. <i>Journal of Acquired Immune Deficiency Syndromes</i>. <b>55</b> (2): 143\u20137. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1097/QAI.0b013e3181eb301e\">10.1097/QAI.0b013e3181eb301e</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3509795\">3509795</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/20683195\">20683195</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Acquired+Immune+Deficiency+Syndromes&amp;rft.atitle=The+role+of+transplacental+microtransfusions+of+maternal+lymphocytes+in+in+utero+HIV+transmission&amp;rft.volume=55&amp;rft.issue=2&amp;rft.pages=143-7&amp;rft.date=2010-10&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3509795&amp;rft_id=info%3Apmid%2F20683195&amp;rft_id=info%3Adoi%2F10.1097%2FQAI.0b013e3181eb301e&amp;rft.aulast=Lee&amp;rft.aufirst=TH&amp;rft.au=Chafets%2C+DM&amp;rft.au=Biggar%2C+RJ&amp;rft.au=McCune%2C+JM&amp;rft.au=Busch%2C+MP&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3509795&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHIV+and+pregnancy\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-24\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-24\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Garcia PM, Kalish LA, Pitt J, Minkoff H, Quinn TC, Burchett SK,  et al. (August 1999). \"Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. Women and Infants Transmission Study Group\". <i>The New England Journal of Medicine</i>. <b>341</b> (6): 394\u2013402. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1056/NEJM199908053410602\">10.1056/NEJM199908053410602</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/10432324\">10432324</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+England+Journal+of+Medicine&amp;rft.atitle=Maternal+levels+of+plasma+human+immunodeficiency+virus+type+1+RNA+and+the+risk+of+perinatal+transmission.+Women+and+Infants+Transmission+Study+Group&amp;rft.volume=341&amp;rft.issue=6&amp;rft.pages=394-402&amp;rft.date=1999-08&amp;rft_id=info%3Adoi%2F10.1056%2FNEJM199908053410602&amp;rft_id=info%3Apmid%2F10432324&amp;rft.aulast=Garcia&amp;rft.aufirst=PM&amp;rft.au=Kalish%2C+LA&amp;rft.au=Pitt%2C+J&amp;rft.au=Minkoff%2C+H&amp;rft.au=Quinn%2C+TC&amp;rft.au=Burchett%2C+SK&amp;rft.au=Kornegay%2C+J&amp;rft.au=Jackson%2C+B&amp;rft.au=Moye%2C+J&amp;rft.au=Hanson%2C+C&amp;rft.au=Zorrilla%2C+C&amp;rft.au=Lew%2C+JF&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHIV+and+pregnancy\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-25\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-25\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">European Collaborative Study (February 2005). \"Mother-to-child transmission of HIV infection in the era of highly active antiretroviral therapy\". <i>Clinical Infectious Diseases</i>. <b>40</b> (3): 458\u201365. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1086/427287\">10.1086/427287</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/15668871\">15668871</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Clinical+Infectious+Diseases&amp;rft.atitle=Mother-to-child+transmission+of+HIV+infection+in+the+era+of+highly+active+antiretroviral+therapy&amp;rft.volume=40&amp;rft.issue=3&amp;rft.pages=458-65&amp;rft.date=2005-02&amp;rft_id=info%3Adoi%2F10.1086%2F427287&amp;rft_id=info%3Apmid%2F15668871&amp;rft.au=European+Collaborative+Study&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHIV+and+pregnancy\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-26\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-26\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Townsend CL, Byrne L, Cortina-Borja M, Thorne C, de Ruiter A, Lyall H,  et al. (April 2014). \"Earlier initiation of ART and further decline in mother-to-child HIV transmission rates, 2000-2011\". <i>Aids</i>. <b>28</b> (7): 1049\u201357. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1097/QAD.0000000000000212\">10.1097/QAD.0000000000000212</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/24566097\">24566097</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Aids&amp;rft.atitle=Earlier+initiation+of+ART+and+further+decline+in+mother-to-child+HIV+transmission+rates%2C+2000-2011&amp;rft.volume=28&amp;rft.issue=7&amp;rft.pages=1049-57&amp;rft.date=2014-04&amp;rft_id=info%3Adoi%2F10.1097%2FQAD.0000000000000212&amp;rft_id=info%3Apmid%2F24566097&amp;rft.aulast=Townsend&amp;rft.aufirst=CL&amp;rft.au=Byrne%2C+L&amp;rft.au=Cortina-Borja%2C+M&amp;rft.au=Thorne%2C+C&amp;rft.au=de+Ruiter%2C+A&amp;rft.au=Lyall%2C+H&amp;rft.au=Taylor%2C+GP&amp;rft.au=Peckham%2C+CS&amp;rft.au=Tookey%2C+PA&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHIV+and+pregnancy\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-27\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-27\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Hoffman RM, Black V, Technau K, van der Merwe KJ, Currier J, Coovadia A, Chersich M (May 2010). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC2880466\">\"Effects of highly active antiretroviral therapy duration and regimen on risk for mother-to-child transmission of HIV in Johannesburg, South Africa\"</a>. <i>Journal of Acquired Immune Deficiency Syndromes</i>. <b>54</b> (1): 35\u201341. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1097/QAI.0b013e3181cf9979\">10.1097/QAI.0b013e3181cf9979</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC2880466\">2880466</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/20216425\">20216425</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Acquired+Immune+Deficiency+Syndromes&amp;rft.atitle=Effects+of+highly+active+antiretroviral+therapy+duration+and+regimen+on+risk+for+mother-to-child+transmission+of+HIV+in+Johannesburg%2C+South+Africa&amp;rft.volume=54&amp;rft.issue=1&amp;rft.pages=35-41&amp;rft.date=2010-05&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2880466&amp;rft_id=info%3Apmid%2F20216425&amp;rft_id=info%3Adoi%2F10.1097%2FQAI.0b013e3181cf9979&amp;rft.aulast=Hoffman&amp;rft.aufirst=RM&amp;rft.au=Black%2C+V&amp;rft.au=Technau%2C+K&amp;rft.au=van+der+Merwe%2C+KJ&amp;rft.au=Currier%2C+J&amp;rft.au=Coovadia%2C+A&amp;rft.au=Chersich%2C+M&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2880466&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHIV+and+pregnancy\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-:10-28\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-:10_28-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-:10_28-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-:10_28-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-:10_28-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-:10_28-4\"><sup><i><b>e</b></i></sup></a> <a href=\"#cite_ref-:10_28-5\"><sup><i><b>f</b></i></sup></a> <a href=\"#cite_ref-:10_28-6\"><sup><i><b>g</b></i></sup></a> <a href=\"#cite_ref-:10_28-7\"><sup><i><b>h</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation book\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.sahivsoc.org/Files/ART%20Guidelines%2015052015.pdf\"><i>National Consolidated Guidelines for the prevention of mother-to-child transmission of HIV (PMTCT) and the management of HIV in children, adolescents and adults</i></a> <span style=\"font-size:85%;\">(PDF)</span>. National Department of Health, South Africa. April 2015.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=National+Consolidated+Guidelines+for+the+prevention+of+mother-to-child+transmission+of+HIV+%28PMTCT%29+and+the+management+of+HIV+in+children%2C+adolescents+and+adults&amp;rft.pub=National+Department+of+Health%2C+South+Africa&amp;rft.date=2015-04&amp;rft_id=http%3A%2F%2Fwww.sahivsoc.org%2FFiles%2FART%2520Guidelines%252015052015.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHIV+and+pregnancy\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-:4-29\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-:4_29-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-:4_29-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"https://aidsinfo.nih.gov/education-materials/fact-sheets/21/52/when-to-start-antiretroviral-therapy\">\"When to Start Antiretroviral Therapy | HIV/AIDS Fact Sheets | Education Materials | AIDSinfo\"</a>. <i>AIDSinfo</i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2015-11-21</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=AIDSinfo&amp;rft.atitle=When+to+Start+Antiretroviral+Therapy+%7C+HIV%2FAIDS+Fact+Sheets+%7C+Education+Materials+%7C+AIDSinfo&amp;rft_id=https%3A%2F%2Faidsinfo.nih.gov%2Feducation-materials%2Ffact-sheets%2F21%2F52%2Fwhen-to-start-antiretroviral-therapy&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHIV+and+pregnancy\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-30\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-30\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Chen JY, Ribaudo HJ, Souda S, Parekh N, Ogwu A, Lockman S,  et al. (December 2012). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3488194\">\"Highly active antiretroviral therapy and adverse birth outcomes among HIV-infected women in Botswana\"</a>. <i>The Journal of Infectious Diseases</i>. <b>206</b> (11): 1695\u2013705. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1093/infdis/jis553\">10.1093/infdis/jis553</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3488194\">3488194</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/23066160\">23066160</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Journal+of+Infectious+Diseases&amp;rft.atitle=Highly+active+antiretroviral+therapy+and+adverse+birth+outcomes+among+HIV-infected+women+in+Botswana&amp;rft.volume=206&amp;rft.issue=11&amp;rft.pages=1695-705&amp;rft.date=2012-12&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3488194&amp;rft_id=info%3Apmid%2F23066160&amp;rft_id=info%3Adoi%2F10.1093%2Finfdis%2Fjis553&amp;rft.aulast=Chen&amp;rft.aufirst=JY&amp;rft.au=Ribaudo%2C+HJ&amp;rft.au=Souda%2C+S&amp;rft.au=Parekh%2C+N&amp;rft.au=Ogwu%2C+A&amp;rft.au=Lockman%2C+S&amp;rft.au=Powis%2C+K&amp;rft.au=Dryden-Peterson%2C+S&amp;rft.au=Creek%2C+T&amp;rft.au=Jimbo%2C+W&amp;rft.au=Madidimalo%2C+T&amp;rft.au=Makhema%2C+J&amp;rft.au=Essex%2C+M&amp;rft.au=Shapiro%2C+RL&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3488194&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHIV+and+pregnancy\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-31\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-31\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021360s024lbl.pdf\">\"HIGHLIGHTS OF PRESCRIBING INFORMATION\"</a> <span style=\"font-size:85%;\">(PDF)</span><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2014-04-11</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=HIGHLIGHTS+OF+PRESCRIBING+INFORMATION&amp;rft_id=http%3A%2F%2Fwww.accessdata.fda.gov%2Fdrugsatfda_docs%2Flabel%2F2010%2F021360s024lbl.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHIV+and+pregnancy\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-:6-32\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-:6_32-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-:6_32-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Ford N, Calmy A, Mofenson L (November 2011). \"Safety of efavirenz in the first trimester of pregnancy:  an updated systematic review and meta-analysis\". <i>Aids</i>. <b>25</b> (18): 2301\u20134. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1097/QAD.0b013e32834cdb71\">10.1097/QAD.0b013e32834cdb71</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/21918421\">21918421</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Aids&amp;rft.atitle=Safety+of+efavirenz+in+the+first+trimester+of+pregnancy%3A++an+updated+systematic+review+and+meta-analysis&amp;rft.volume=25&amp;rft.issue=18&amp;rft.pages=2301-4&amp;rft.date=2011-11&amp;rft_id=info%3Adoi%2F10.1097%2FQAD.0b013e32834cdb71&amp;rft_id=info%3Apmid%2F21918421&amp;rft.aulast=Ford&amp;rft.aufirst=N&amp;rft.au=Calmy%2C+A&amp;rft.au=Mofenson%2C+L&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHIV+and+pregnancy\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-who2013-33\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-who2013_33-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-who2013_33-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.who.int/hiv/pub/guidelines/arv2013/download/en/\">\"WHO | Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection\"</a>. June 30, 2013. p.&#160;38. <a href=\"/wiki/International_Standard_Book_Number\" title=\"International Standard Book Number\">ISBN</a>&#160;<a href=\"/wiki/Special:BookSources/978_92_4_150572_7\" title=\"Special:BookSources/978 92 4 150572 7\">978 92 4 150572 7</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=WHO+%7C+Consolidated+guidelines+on+the+use+of+antiretroviral+drugs+for+treating+and+preventing+HIV+infection&amp;rft.pages=38&amp;rft.date=2013-06-30&amp;rft.isbn=9789241505727&amp;rft_id=http%3A%2F%2Fwww.who.int%2Fhiv%2Fpub%2Fguidelines%2Farv2013%2Fdownload%2Fen%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHIV+and+pregnancy\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-34\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-34\">^</a></b></span> <span class=\"reference-text\"> Wiysonge CS, Ndze VN, Kongnyuy EJ, Shey MS. Vitamin A supplements for reducing mother-to-child HIV transmission. Cochrane Database of Systematic Reviews 2017, Issue 9. Art. No.: CD003648. DOI: 10.1002/14651858.CD003648.pub4.</span>\n</li>\n<li id=\"cite_note-:8-35\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-:8_35-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-:8_35-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.uptodate.com/contents/hiv-and-pregnancy-beyond-the-basics\">\"HIV and pregnancy\"</a>. <i>www.uptodate.com</i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2015-11-21</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=www.uptodate.com&amp;rft.atitle=HIV+and+pregnancy&amp;rft_id=http%3A%2F%2Fwww.uptodate.com%2Fcontents%2Fhiv-and-pregnancy-beyond-the-basics&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHIV+and+pregnancy\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-36\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-36\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Hoddinott P, Tappin D, Wright C (April 2008). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC2323059\">\"Breast feeding\"</a>. <i>BMJ</i>. <b>336</b> (7649): 881\u20137. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1136/bmj.39521.566296.BE\">10.1136/bmj.39521.566296.BE</a>. <a href=\"/wiki/Handle_System\" title=\"Handle System\">hdl</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//hdl.handle.net/1893%2F10055\">1893/10055</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC2323059\">2323059</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/18420694\">18420694</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=BMJ&amp;rft.atitle=Breast+feeding&amp;rft.volume=336&amp;rft.issue=7649&amp;rft.pages=881-7&amp;rft.date=2008-04&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2323059&amp;rft_id=info%3Apmid%2F18420694&amp;rft_id=info%3Ahdl%2F1893%2F10055&amp;rft_id=info%3Adoi%2F10.1136%2Fbmj.39521.566296.BE&amp;rft.aulast=Hoddinott&amp;rft.aufirst=P&amp;rft.au=Tappin%2C+D&amp;rft.au=Wright%2C+C&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2323059&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHIV+and+pregnancy\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid17398310-37\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid17398310_37-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Coovadia HM, Rollins NC, Bland RM, Little K, Coutsoudis A, Bennish ML,  et al. (March 2007). \"Mother-to-child transmission of HIV-1 infection during exclusive breastfeeding in the first 6 months of life: an intervention cohort study\". <i>Lancet</i>. <b>369</b> (9567): 1107\u201316. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/S0140-6736%2807%2960283-9\">10.1016/S0140-6736(07)60283-9</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/17398310\">17398310</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Lancet&amp;rft.atitle=Mother-to-child+transmission+of+HIV-1+infection+during+exclusive+breastfeeding+in+the+first+6+months+of+life%3A+an+intervention+cohort+study&amp;rft.volume=369&amp;rft.issue=9567&amp;rft.pages=1107-16&amp;rft.date=2007-03&amp;rft_id=info%3Adoi%2F10.1016%2FS0140-6736%2807%2960283-9&amp;rft_id=info%3Apmid%2F17398310&amp;rft.aulast=Coovadia&amp;rft.aufirst=HM&amp;rft.au=Rollins%2C+NC&amp;rft.au=Bland%2C+RM&amp;rft.au=Little%2C+K&amp;rft.au=Coutsoudis%2C+A&amp;rft.au=Bennish%2C+ML&amp;rft.au=Newell%2C+ML&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHIV+and+pregnancy\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid10463709-38\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid10463709_38-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Miotti PG, Taha TE, Kumwenda NI, Broadhead R, Mtimavalye LA, Van der Hoeven L,  et al. (August 1999). \"HIV transmission through breastfeeding: a study in Malawi\". <i>Jama</i>. <b>282</b> (8): 744\u20139. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1001/jama.282.8.744\">10.1001/jama.282.8.744</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/10463709\">10463709</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Jama&amp;rft.atitle=HIV+transmission+through+breastfeeding%3A+a+study+in+Malawi&amp;rft.volume=282&amp;rft.issue=8&amp;rft.pages=744-9&amp;rft.date=1999-08&amp;rft_id=info%3Adoi%2F10.1001%2Fjama.282.8.744&amp;rft_id=info%3Apmid%2F10463709&amp;rft.aulast=Miotti&amp;rft.aufirst=PG&amp;rft.au=Taha%2C+TE&amp;rft.au=Kumwenda%2C+NI&amp;rft.au=Broadhead%2C+R&amp;rft.au=Mtimavalye%2C+LA&amp;rft.au=Van+der+Hoeven%2C+L&amp;rft.au=Chiphangwi%2C+JD&amp;rft.au=Liomba%2C+G&amp;rft.au=Biggar%2C+RJ&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHIV+and+pregnancy\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-39\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-39\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Bispo S, Chikhungu L, Rollins N, Siegfried N, Newell ML (February 2017). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC5467610\">\"Postnatal HIV transmission in breastfed infants of HIV-infected women on ART: a systematic review and meta-analysis\"</a>. <i>Journal of the International AIDS Society</i>. <b>20</b> (1): 21251. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.7448/IAS.20.1.21251\">10.7448/IAS.20.1.21251</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC5467610\">5467610</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/28362072\">28362072</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+the+International+AIDS+Society&amp;rft.atitle=Postnatal+HIV+transmission+in+breastfed+infants+of+HIV-infected+women+on+ART%3A+a+systematic+review+and+meta-analysis&amp;rft.volume=20&amp;rft.issue=1&amp;rft.pages=21251&amp;rft.date=2017-02&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5467610&amp;rft_id=info%3Apmid%2F28362072&amp;rft_id=info%3Adoi%2F10.7448%2FIAS.20.1.21251&amp;rft.aulast=Bispo&amp;rft.aufirst=S&amp;rft.au=Chikhungu%2C+L&amp;rft.au=Rollins%2C+N&amp;rft.au=Siegfried%2C+N&amp;rft.au=Newell%2C+ML&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5467610&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHIV+and+pregnancy\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-40\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-40\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Chikhungu LC, Bispo S, Rollins N, Siegfried N, Newell ML (July 2016). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC5096069\">\"HIV-free survival at 12-24 months in breastfed infants of HIV-infected women on antiretroviral treatment\"</a>. <i>Tropical Medicine &amp; International Health</i>. <b>21</b> (7): 820\u20138. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1111/tmi.12710\">10.1111/tmi.12710</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC5096069\">5096069</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/27120500\">27120500</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Tropical+Medicine+%26+International+Health&amp;rft.atitle=HIV-free+survival+at+12-24+months+in+breastfed+infants+of+HIV-infected+women+on+antiretroviral+treatment&amp;rft.volume=21&amp;rft.issue=7&amp;rft.pages=820-8&amp;rft.date=2016-07&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5096069&amp;rft_id=info%3Apmid%2F27120500&amp;rft_id=info%3Adoi%2F10.1111%2Ftmi.12710&amp;rft.aulast=Chikhungu&amp;rft.aufirst=LC&amp;rft.au=Bispo%2C+S&amp;rft.au=Rollins%2C+N&amp;rft.au=Siegfried%2C+N&amp;rft.au=Newell%2C+ML&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5096069&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHIV+and+pregnancy\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-41\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-41\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.unicef.org/programme/breastfeeding/feeding.htm\">\"WHO/UNAIDS/UNICEF infant feeding guidelines\"</a>. <i>www.unicef.org</i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2018-09-06</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=www.unicef.org&amp;rft.atitle=WHO%2FUNAIDS%2FUNICEF+infant+feeding+guidelines&amp;rft_id=https%3A%2F%2Fwww.unicef.org%2Fprogramme%2Fbreastfeeding%2Ffeeding.htm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHIV+and+pregnancy\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-MadhiCutland2014-42\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-MadhiCutland2014_42-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Madhi SA, Cutland CL, Kuwanda L, Weinberg A, Hugo A, Jones S,  et al. (September 2014). \"Influenza vaccination of pregnant women and protection of their infants\". <i>The New England Journal of Medicine</i>. <b>371</b> (10): 918\u201331. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1056/NEJMoa1401480\">10.1056/NEJMoa1401480</a>. <a href=\"/wiki/Handle_System\" title=\"Handle System\">hdl</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//hdl.handle.net/2263%2F42412\">2263/42412</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/25184864\">25184864</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+England+Journal+of+Medicine&amp;rft.atitle=Influenza+vaccination+of+pregnant+women+and+protection+of+their+infants&amp;rft.volume=371&amp;rft.issue=10&amp;rft.pages=918-31&amp;rft.date=2014-09&amp;rft_id=info%3Ahdl%2F2263%2F42412&amp;rft_id=info%3Apmid%2F25184864&amp;rft_id=info%3Adoi%2F10.1056%2FNEJMoa1401480&amp;rft.aulast=Madhi&amp;rft.aufirst=SA&amp;rft.au=Cutland%2C+CL&amp;rft.au=Kuwanda%2C+L&amp;rft.au=Weinberg%2C+A&amp;rft.au=Hugo%2C+A&amp;rft.au=Jones%2C+S&amp;rft.au=Adrian%2C+PV&amp;rft.au=van+Niekerk%2C+N&amp;rft.au=Treurnicht%2C+F&amp;rft.au=Ortiz%2C+JR&amp;rft.au=Venter%2C+M&amp;rft.au=Violari%2C+A&amp;rft.au=Neuzil%2C+KM&amp;rft.au=Sim%C3%B5es%2C+EA&amp;rft.au=Klugman%2C+KP&amp;rft.au=Nunes%2C+MC&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHIV+and+pregnancy\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-43\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-43\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Solomon SS, Hawcroft CS, Narasimhan P, Subbaraman R, Srikrishnan AK, Cecelia AJ,  et al. (May 2008). \"Comorbidities among HIV-infected injection drug users in Chennai, India\". <i>The Indian Journal of Medical Research</i>. <b>127</b> (5): 447\u201352. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/18653907\">18653907</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Indian+Journal+of+Medical+Research&amp;rft.atitle=Comorbidities+among+HIV-infected+injection+drug+users+in+Chennai%2C+India&amp;rft.volume=127&amp;rft.issue=5&amp;rft.pages=447-52&amp;rft.date=2008-05&amp;rft_id=info%3Apmid%2F18653907&amp;rft.aulast=Solomon&amp;rft.aufirst=SS&amp;rft.au=Hawcroft%2C+CS&amp;rft.au=Narasimhan%2C+P&amp;rft.au=Subbaraman%2C+R&amp;rft.au=Srikrishnan%2C+AK&amp;rft.au=Cecelia%2C+AJ&amp;rft.au=Suresh+Kumar%2C+M&amp;rft.au=Solomon%2C+S&amp;rft.au=Gallant%2C+JE&amp;rft.au=Celentano%2C+DD&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHIV+and+pregnancy\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-44\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-44\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Read JS (December 2007). \"Diagnosis of HIV-1 infection in children younger than 18 months in the United States\". <i>Pediatrics</i>. <b>120</b> (6): e1547\u201362. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1542/peds.2007-2951\">10.1542/peds.2007-2951</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/18055670\">18055670</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Pediatrics&amp;rft.atitle=Diagnosis+of+HIV-1+infection+in+children+younger+than+18+months+in+the+United+States&amp;rft.volume=120&amp;rft.issue=6&amp;rft.pages=e1547-62&amp;rft.date=2007-12&amp;rft_id=info%3Adoi%2F10.1542%2Fpeds.2007-2951&amp;rft_id=info%3Apmid%2F18055670&amp;rft.aulast=Read&amp;rft.aufirst=JS&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHIV+and+pregnancy\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-45\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-45\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://aidsinfo.nih.gov/guidelines\">\"Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV Transmission in the United States\"</a><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">21 November</span> 2015</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Recommendations+for+Use+of+Antiretroviral+Drugs+in+Pregnant+HIV-1-Infected+Women+for+Maternal+Health+and+Interventions+to+Reduce+Perinatal+HIV+Transmission+in+the+United+States.&amp;rft_id=http%3A%2F%2Faidsinfo.nih.gov%2Fguidelines&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHIV+and+pregnancy\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n</ol></div></div>\n<h2><span class=\"mw-headline\" id=\"External_links\">External links</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=HIV_and_pregnancy&amp;action=edit&amp;section=12\" title=\"Edit section: External links\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<ul><li><a rel=\"nofollow\" class=\"external text\" href=\"http://www.aidsinfo.nih.gov/\">aidsinfo.nih.gov</a></li></ul>\n<p><img alt=\"\" src=\"//upload.wikimedia.org/wikipedia/en/thumb/6/62/PD-icon.svg/12px-PD-icon.svg.png\" width=\"12\" height=\"12\" srcset=\"//upload.wikimedia.org/wikipedia/en/thumb/6/62/PD-icon.svg/18px-PD-icon.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/6/62/PD-icon.svg/24px-PD-icon.svg.png 2x\" data-file-width=\"196\" data-file-height=\"196\" />&#160;This article incorporates&#160;<a href=\"/wiki/Copyright_status_of_work_by_the_U.S._government\" title=\"Copyright status of work by the U.S. government\">public domain material</a> from websites or documents of&#32;the <a href=\"/wiki/United_States_Government\" class=\"mw-redirect\" title=\"United States Government\">United States Government</a>.\n</p>\n<!-- \nNewPP limit report\nParsed by mw1242\nCached time: 20180908064708\nCache expiry: 1900800\nDynamic content: false\nCPU time usage: 0.496 seconds\nReal time usage: 0.533 seconds\nPreprocessor visited node count: 2044/1000000\nPreprocessor generated node count: 0/1500000\nPost\u2010expand include size: 97252/2097152 bytes\nTemplate argument size: 153/2097152 bytes\nHighest expansion depth: 7/40\nExpensive parser function count: 1/500\nUnstrip recursion depth: 0/20\nUnstrip post\u2010expand size: 74139/5000000 bytes\nNumber of Wikibase entities loaded: 0/400\nLua time usage: 0.273/10.000 seconds\nLua memory usage: 3.31 MB/50 MB\n-->\n<!--\nTransclusion expansion time report (%,ms,calls,template)\n100.00%  425.863      1 -total\n 87.20%  371.355      1 Template:Reflist\n 47.00%  200.163     27 Template:Cite_journal\n 20.90%   89.020     14 Template:Cite_web\n  4.87%   20.746      1 Template:Further_information\n  3.24%   13.793      3 Template:Cite_book\n  1.23%    5.250      1 Template:US_government_sources\n  0.85%    3.610      1 Template:Include-USGov\n  0.42%    1.786      1 Template:Main_other\n-->\n\n<!-- Saved in parser cache with key enwiki:pcache:idhash:43456997-0!canonical and timestamp 20180908064707 and revision id 858584416\n -->\n</div>"},"langlinks":[{"lang":"fr","url":"https://fr.wikipedia.org/wiki/Transmission_du_VIH_%C3%A0_l%27accouchement","langname":"French","autonym":"fran\u00e7ais","*":"Transmission du VIH \u00e0 l'accouchement"},{"lang":"he","url":"https://he.wikipedia.org/wiki/%D7%94%D7%A8%D7%99%D7%95%D7%9F_%D7%95-HIV","langname":"Hebrew","autonym":"\u05e2\u05d1\u05e8\u05d9\u05ea","*":"\u05d4\u05e8\u05d9\u05d5\u05df \u05d5-HIV"}],"categories":[{"sortkey":"","hidden":"","*":"CS1_maint:_Uses_authors_parameter"},{"sortkey":"","hidden":"","*":"Wikipedia_articles_incorporating_text_from_public_domain_works_of_the_United_States_Government"},{"sortkey":"","*":"HIV/AIDS"},{"sortkey":"","*":"Midwifery"}],"links":[{"ns":0,"exists":"","*":"United States Government"},{"ns":0,"exists":"","*":"Antibody"},{"ns":0,"exists":"","*":"Antiretroviral therapy"},{"ns":0,"exists":"","*":"Artificial insemination"},{"ns":0,"exists":"","*":"Assisted reproductive technology"},{"ns":0,"exists":"","*":"Atazanavir"},{"ns":0,"exists":"","*":"Atripla"},{"ns":0,"exists":"","*":"Brand name"},{"ns":0,"exists":"","*":"Breast milk"},{"ns":0,"exists":"","*":"Breastfeed"},{"ns":0,"exists":"","*":"Breastfeeding"},{"ns":0,"exists":"","*":"CD4 count"},{"ns":0,"exists":"","*":"Centers for Disease Control and Prevention"},{"ns":0,"exists":"","*":"Cesarean sections"},{"ns":0,"exists":"","*":"Childbirth"},{"ns":0,"exists":"","*":"Comorbidity"},{"ns":0,"exists":"","*":"Contraindication"},{"ns":0,"exists":"","*":"Copyright status of work by the U.S. government"},{"ns":0,"exists":"","*":"Cuba"},{"ns":0,"exists":"","*":"DNA"},{"ns":0,"exists":"","*":"Darunavir"},{"ns":0,"exists":"","*":"Developed countries"},{"ns":0,"exists":"","*":"Developing countries"},{"ns":0,"exists":"","*":"Diagnosis of HIV/AIDS"},{"ns":0,"exists":"","*":"Didanosine"},{"ns":0,"exists":"","*":"Digital object identifier"},{"ns":0,"exists":"","*":"Efavirenz"},{"ns":0,"exists":"","*":"Emtricitabine"},{"ns":0,"exists":"","*":"Food and Drug Administration"},{"ns":0,"exists":"","*":"Gestational diabetes"},{"ns":0,"exists":"","*":"HIV"},{"ns":0,"exists":"","*":"HIV/AIDS"},{"ns":0,"exists":"","*":"HIV Testing"},{"ns":0,"exists":"","*":"HPTN 052"},{"ns":0,"exists":"","*":"Handle System"},{"ns":0,"exists":"","*":"Hepatitis B"},{"ns":0,"exists":"","*":"Human milk banking in North America"},{"ns":0,"exists":"","*":"Hyperbilirubinemia"},{"ns":0,"exists":"","*":"Hyperglycemia"},{"ns":0,"exists":"","*":"Immune system"},{"ns":0,"exists":"","*":"In utero"},{"ns":0,"exists":"","*":"In vitro fertilization"},{"ns":0,"exists":"","*":"Influenza vaccine"},{"ns":0,"exists":"","*":"Integrase inhibitor"},{"ns":0,"exists":"","*":"International Standard Book Number"},{"ns":0,"exists":"","*":"Intrauterine insemination"},{"ns":0,"exists":"","*":"Intravenous therapy"},{"ns":0,"exists":"","*":"Lactic acidosis"},{"ns":0,"exists":"","*":"Lamivudine"},{"ns":0,"exists":"","*":"Lopinavir"},{"ns":0,"exists":"","*":"Management of HIV/AIDS"},{"ns":0,"exists":"","*":"Maternal antibodies"},{"ns":0,"exists":"","*":"Nevirapine"},{"ns":0,"exists":"","*":"Nifedipine"},{"ns":0,"exists":"","*":"Non-nucleoside reverse transcriptase inhibitor"},{"ns":0,"exists":"","*":"Nucleoside reverse transcriptase inhibitor"},{"ns":0,"exists":"","*":"Pan American Health Organization"},{"ns":0,"exists":"","*":"Pneumocystis pneumonia"},{"ns":0,"exists":"","*":"Polymerase chain reaction"},{"ns":0,"exists":"","*":"Post-exposure prophylaxis"},{"ns":0,"exists":"","*":"Pre-exposure prophylaxis"},{"ns":0,"exists":"","*":"Pregnancy"},{"ns":0,"exists":"","*":"Pregnancy category"},{"ns":0,"exists":"","*":"Prenatal care"},{"ns":0,"exists":"","*":"Protease inhibitor (pharmacology)"},{"ns":0,"exists":"","*":"PubMed Central"},{"ns":0,"exists":"","*":"PubMed Identifier"},{"ns":0,"exists":"","*":"Raltegravir"},{"ns":0,"exists":"","*":"Ritonavir"},{"ns":0,"exists":"","*":"Rupture of membranes"},{"ns":0,"exists":"","*":"Screening (medicine)"},{"ns":0,"exists":"","*":"Serodiscordant"},{"ns":0,"exists":"","*":"South Africa"},{"ns":0,"exists":"","*":"South African Department of Health"},{"ns":0,"exists":"","*":"Sperm washing"},{"ns":0,"exists":"","*":"Stavudine"},{"ns":0,"exists":"","*":"Sub-Saharan Africa"},{"ns":0,"exists":"","*":"Tenofovir"},{"ns":0,"exists":"","*":"Tenofovir disoproxil"},{"ns":0,"exists":"","*":"Teratogen"},{"ns":0,"exists":"","*":"Trade name"},{"ns":0,"exists":"","*":"Trimethoprim/sulfamethoxazole"},{"ns":0,"exists":"","*":"UNAIDS"},{"ns":0,"exists":"","*":"United States"},{"ns":0,"exists":"","*":"Vertically transmitted infection"},{"ns":0,"exists":"","*":"Viral load"},{"ns":0,"exists":"","*":"Viral load monitoring for HIV"},{"ns":0,"exists":"","*":"Vitamin A"},{"ns":0,"exists":"","*":"WHO"},{"ns":0,"exists":"","*":"World Health Organization"},{"ns":0,"exists":"","*":"Zidovudine"},{"ns":0,"*":"Exclusive breastfeeding"},{"ns":14,"exists":"","*":"Category:CS1 maint: Uses authors parameter"}],"templates":[{"ns":10,"exists":"","*":"Template:Further information"},{"ns":10,"exists":"","*":"Template:Further"},{"ns":10,"exists":"","*":"Template:Reflist"},{"ns":10,"exists":"","*":"Template:Cite web"},{"ns":10,"exists":"","*":"Template:Cite book"},{"ns":10,"exists":"","*":"Template:Cite journal"},{"ns":10,"exists":"","*":"Template:Main other"},{"ns":10,"exists":"","*":"Template:US government sources"},{"ns":10,"exists":"","*":"Template:Include-USGov"},{"ns":828,"exists":"","*":"Module:Labelled list hatnote"},{"ns":828,"exists":"","*":"Module:Hatnote"},{"ns":828,"exists":"","*":"Module:Hatnote list"},{"ns":828,"exists":"","*":"Module:Arguments"},{"ns":828,"exists":"","*":"Module:Citation/CS1"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Configuration"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Whitelist"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Utilities"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Date validation"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Identifiers"},{"ns":828,"exists":"","*":"Module:Citation/CS1/COinS"},{"ns":828,"exists":"","*":"Module:Check for unknown parameters"}],"images":["Lock-green.svg","PD-icon.svg"],"externallinks":["https://web.archive.org/web/20150421024106/http://aidsinfo.nih.gov/contentfiles/perinatal_FS_en.pdf","http://aidsinfo.nih.gov/contentfiles/perinatal_FS_en.pdf","http://apps.who.int/iris/bitstream/handle/10665/246260/9789241549707-eng.pdf?sequence=1","//doi.org/10.1586/eri.10.94","//www.ncbi.nlm.nih.gov/pubmed/20954881","http://www.who.int/hiv/topics/mtct/en/","http://apps.who.int/iris/bitstream/10665/82207/1/WHO_RHR_13.02_eng.pdf","http://www.unaids.org/sites/default/files/media_asset/09_ChildrenandpregnantwomenlivingwithHIV.pdf","http://www.who.int/bulletin/volumes/91/1/12-106807/en/","http://www.who.int/mediacentre/news/releases/2015/mtct-hiv-cuba/en/","//doi.org/10.1093/humupd/dml052","//www.ncbi.nlm.nih.gov/pubmed/17099206","//www.ncbi.nlm.nih.gov/pmc/articles/PMC3200068","//doi.org/10.1056/NEJMoa1105243","//www.ncbi.nlm.nih.gov/pubmed/21767103","//doi.org/10.1093/humupd/dms046","//www.ncbi.nlm.nih.gov/pubmed/23146867","http://aidsinfo.nih.gov/contentfiles/lvguidelines/PerinatalGL.pdf","http://nrs.harvard.edu/urn-3:HUL.InstRepos:26667502","//doi.org/10.1056/NEJMoa1110711","//www.ncbi.nlm.nih.gov/pubmed/22784038","//doi.org/10.1097/00126334-200012010-00008","//www.ncbi.nlm.nih.gov/pubmed/11114835","//www.ncbi.nlm.nih.gov/pmc/articles/PMC3165097","//doi.org/10.1016/j.fertnstert.2011.05.094","//www.ncbi.nlm.nih.gov/pubmed/21722892","//www.ncbi.nlm.nih.gov/pubmed/2109169","https://www.cdc.gov/hiv/group/gender/pregnantwomen/opt-out.html","https://aidsinfo.nih.gov/contentfiles/hivtestingandpregnancy_fs_en.pdf","//doi.org/10.1093/cid/cit281","//www.ncbi.nlm.nih.gov/pubmed/23667267","//doi.org/10.1016/j.jcv.2013.07.002","//www.ncbi.nlm.nih.gov/pubmed/23911678","//doi.org/10.1097/00006250-200304000-00038","//www.ncbi.nlm.nih.gov/pubmed/12681888","//www.ncbi.nlm.nih.gov/pmc/articles/PMC3509795","//doi.org/10.1097/QAI.0b013e3181eb301e","//www.ncbi.nlm.nih.gov/pubmed/20683195","//doi.org/10.1056/NEJM199908053410602","//www.ncbi.nlm.nih.gov/pubmed/10432324","//doi.org/10.1086/427287","//www.ncbi.nlm.nih.gov/pubmed/15668871","//doi.org/10.1097/QAD.0000000000000212","//www.ncbi.nlm.nih.gov/pubmed/24566097","//www.ncbi.nlm.nih.gov/pmc/articles/PMC2880466","//doi.org/10.1097/QAI.0b013e3181cf9979","//www.ncbi.nlm.nih.gov/pubmed/20216425","http://www.sahivsoc.org/Files/ART%20Guidelines%2015052015.pdf","https://aidsinfo.nih.gov/education-materials/fact-sheets/21/52/when-to-start-antiretroviral-therapy","//www.ncbi.nlm.nih.gov/pmc/articles/PMC3488194","//doi.org/10.1093/infdis/jis553","//www.ncbi.nlm.nih.gov/pubmed/23066160","http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021360s024lbl.pdf","//doi.org/10.1097/QAD.0b013e32834cdb71","//www.ncbi.nlm.nih.gov/pubmed/21918421","http://www.who.int/hiv/pub/guidelines/arv2013/download/en/","http://www.uptodate.com/contents/hiv-and-pregnancy-beyond-the-basics","//www.ncbi.nlm.nih.gov/pmc/articles/PMC2323059","//doi.org/10.1136/bmj.39521.566296.BE","//hdl.handle.net/1893%2F10055","//www.ncbi.nlm.nih.gov/pubmed/18420694","//doi.org/10.1016/S0140-6736(07)60283-9","//www.ncbi.nlm.nih.gov/pubmed/17398310","//doi.org/10.1001/jama.282.8.744","//www.ncbi.nlm.nih.gov/pubmed/10463709","//www.ncbi.nlm.nih.gov/pmc/articles/PMC5467610","//doi.org/10.7448/IAS.20.1.21251","//www.ncbi.nlm.nih.gov/pubmed/28362072","//www.ncbi.nlm.nih.gov/pmc/articles/PMC5096069","//doi.org/10.1111/tmi.12710","//www.ncbi.nlm.nih.gov/pubmed/27120500","https://www.unicef.org/programme/breastfeeding/feeding.htm","//doi.org/10.1056/NEJMoa1401480","//hdl.handle.net/2263%2F42412","//www.ncbi.nlm.nih.gov/pubmed/25184864","//www.ncbi.nlm.nih.gov/pubmed/18653907","//doi.org/10.1542/peds.2007-2951","//www.ncbi.nlm.nih.gov/pubmed/18055670","http://aidsinfo.nih.gov/guidelines","http://www.aidsinfo.nih.gov/"],"sections":[{"toclevel":1,"level":"2","line":"Pregnancy planning","number":"1","index":"1","fromtitle":"HIV_and_pregnancy","byteoffset":5323,"anchor":"Pregnancy_planning"},{"toclevel":1,"level":"2","line":"HIV testing in pregnancy","number":"2","index":"2","fromtitle":"HIV_and_pregnancy","byteoffset":11967,"anchor":"HIV_testing_in_pregnancy"},{"toclevel":1,"level":"2","line":"Prevention of mother-to-child transmission","number":"3","index":"3","fromtitle":"HIV_and_pregnancy","byteoffset":16136,"anchor":"Prevention_of_mother-to-child_transmission"},{"toclevel":2,"level":"3","line":"Indications to start medications","number":"3.1","index":"4","fromtitle":"HIV_and_pregnancy","byteoffset":21381,"anchor":"Indications_to_start_medications"},{"toclevel":2,"level":"3","line":"Medications during pregnancy","number":"3.2","index":"5","fromtitle":"HIV_and_pregnancy","byteoffset":22399,"anchor":"Medications_during_pregnancy"},{"toclevel":2,"level":"3","line":"Nutritional supplements","number":"3.3","index":"6","fromtitle":"HIV_and_pregnancy","byteoffset":29227,"anchor":"Nutritional_supplements"},{"toclevel":2,"level":"3","line":"Labor and delivery","number":"3.4","index":"7","fromtitle":"HIV_and_pregnancy","byteoffset":30119,"anchor":"Labor_and_delivery"},{"toclevel":2,"level":"3","line":"Breastfeeding","number":"3.5","index":"8","fromtitle":"HIV_and_pregnancy","byteoffset":32042,"anchor":"Breastfeeding"},{"toclevel":1,"level":"2","line":"Other considerations during pregnancy","number":"4","index":"9","fromtitle":"HIV_and_pregnancy","byteoffset":38584,"anchor":"Other_considerations_during_pregnancy"},{"toclevel":1,"level":"2","line":"Postnatal care","number":"5","index":"10","fromtitle":"HIV_and_pregnancy","byteoffset":40289,"anchor":"Postnatal_care"},{"toclevel":1,"level":"2","line":"References","number":"6","index":"11","fromtitle":"HIV_and_pregnancy","byteoffset":42730,"anchor":"References"},{"toclevel":1,"level":"2","line":"External links","number":"7","index":"12","fromtitle":"HIV_and_pregnancy","byteoffset":42760,"anchor":"External_links"}],"parsewarnings":[],"displaytitle":"HIV and pregnancy","iwlinks":[],"properties":[{"name":"wikibase_item","*":"Q3537721"}]}}